https://www.pharmaceutical-business-review.com/news/sensorion-receives-ema-agreement-on-the-pediatric-investigation-plan-for-arazasetron-in-two-indications/attachment/child-1439468_960_720/ 2019-07-01T10:48:16+00:00 https://www.pharmaceutical-business-review.com/news/chmp-evenity-negative-opinion/attachment/amgenheadquarters-2/ 2019-07-01T11:45:39+00:00 https://www.pharmaceutical-business-review.com/news/novartis-takeda-xiidra-2/attachment/novartistower/ 2019-07-02T07:45:08+00:00 https://www.pharmaceutical-business-review.com/news/puma-biotechnology-submits-snda-to-fda-for-neratinib-to-treat-her2-positive-metastatic-breast-cancer/attachment/fdadrug-25/ 2019-07-02T07:50:39+00:00 https://www.pharmaceutical-business-review.com/news/vedanta-biosciences-enrols-first-patient-in-ve416-phase-1b-2-food-allergy-clinical-study/attachment/ved-laboratory-3827745_960_720/ 2019-07-02T10:28:37+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-yuhan-nash-molecule/attachment/siedziba_boehringer_ingelheim_w_polsce/ 2019-07-02T11:44:19+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/astm-c114-15-compliance-for-cement-fused-beads-in-ten-minutes/attachment/ane4_18328_astm_c114_15_compliance_for_cement_fused_beads_in_10_minutes/ 2019-07-02T14:08:01+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/confirming-the-pharmaceutical-equivalence-of-oral-solid-dose-products/attachment/an20181205confirmingpharmaceuticalequivalenceosdproducts/ 2019-07-02T14:14:02+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/pushing-the-limits-of-dynamic-light-scattering/attachment/an20181205confirmingpharmaceuticalequivalenceosdproducts-2/ 2019-07-02T14:15:26+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/early-detection-of-oak-wilt-disease-in-quercus-ssp-a-hyperspectral-approach/attachment/_blake1/ 2019-07-02T14:17:42+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/comparing-multi-detector-gpc-and-apc-for-polyalphaolefin-analysis/attachment/an181205multidetectionofpolyalphaolefin/ 2019-07-02T14:21:01+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/using-xrd-to-cut-co2/attachment/icr_article_september_2013/ 2019-07-02T14:23:33+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/improved-component-resolution-with-multi-angle-dls-madls/attachment/wp180926improvedcomponentresolutionmadls/ 2019-07-02T14:25:33+00:00 https://www.pharmaceutical-business-review.com/news/roche-flu-drug-xofluza/attachment/roche-6/ 2019-07-03T07:25:01+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-launches-oncology-generic-gefitinib-in-13-eu-countries/attachment/sandoz/ 2019-07-03T08:09:51+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-to-begin-clinical-development-of-dcr-a1at-for-a1at-deficiency-associated-liver-disease/attachment/cli-test-214185_960_720/ 2019-07-03T10:24:48+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-libtayo-ec-approval/attachment/libtayoproductshot_1524600959932-25-hr/ 2019-07-03T11:44:43+00:00 https://www.pharmaceutical-business-review.com/news/ec-viiv-healthcare-dovato/attachment/hivinfection/ 2019-07-04T07:05:27+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-treatment-for-refractory-multiple-myeloma/attachment/fdadrug-26/ 2019-07-04T07:51:12+00:00 https://www.pharmaceutical-business-review.com/news/fda-grifols-xembify-immunodeficiencies/attachment/fdadrug-27/ 2019-07-05T06:29:22+00:00 https://www.pharmaceutical-business-review.com/news/cantargia-announces-full-recruitment-of-can04-monotherapy-arm-in-ongoing-phase-iia-clinical-trial/attachment/therapy/ 2019-07-05T10:31:00+00:00 https://www.pharmaceutical-business-review.com/news/valbiotis-announces-positive-results-from-phase-iia-trial-of-valedia-in-prediabetics/attachment/vol-blood-17305_960_720/ 2019-07-05T10:36:49+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-sangamo-hemophilia-study/attachment/pfizer-10/ 2019-07-08T06:29:13+00:00 https://www.pharmaceutical-business-review.com/news/phoremost-instem-enter-structural-biology-alliance/attachment/drug-9/ 2019-07-08T10:34:04+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-servier-announce-initial-phase-1-2-data-of-liposomal-irinotecan-in-metastatic-pancreatic-cancer/attachment/cancer-cells-541954_960_720-9/ 2019-07-08T11:21:45+00:00 https://www.pharmaceutical-business-review.com/news/biondvax-phase-3-m-001-flu-vaccine/attachment/vaccination-67477_960_720/ 2019-07-08T12:13:57+00:00 https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/integrated-industrial-vibratory-sieving-solution-for-high-containment-pharmaceutical-production-lines/attachment/howorth-for-pbr/ 2019-07-08T12:40:01+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-introduces-levothyroxine-sodium-injection-solution/attachment/levo/ 2019-07-09T07:52:23+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-hiv-treatment/attachment/hivtreat/ 2019-07-09T08:13:11+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-vivoryon-qpctl-inhibitors/attachment/morp-mitosis-3876669_960_720/ 2019-07-09T10:22:18+00:00 https://www.pharmaceutical-business-review.com/news/lyndra-therapeutics-and-gilead-sciences-to-collaborate-on-development-of-ultra-long-acting-hiv-therapeutics/attachment/gil-handshake-3298455_960_720/ 2019-07-09T11:06:08+00:00 https://www.pharmaceutical-business-review.com/news/altimmune-spitfire-pharma/attachment/spitfire/ 2019-07-10T06:49:40+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-mercks-sbla-for-keytruda-six-week-dosing-schedule-for-melanoma-and-multiple-other-indications/attachment/fdadrug-28/ 2019-07-10T10:41:32+00:00 https://www.pharmaceutical-business-review.com/news/celsius-therapeutics-signs-collaboration-agreement-with-janssen-to-identify-response-biomarkers-for-ulcerative-colitis/attachment/jann-business-3141342_960_720/ 2019-07-10T10:54:28+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-isatuximab-fda-review/attachment/fda_bldg_51_-_main_entrance_5161374834-3/ 2019-07-10T12:23:39+00:00 https://www.pharmaceutical-business-review.com/suppliers/contract-immune-monitoring-and-research/whitepapers/antigen-specific-t-cell-lineages/attachment/detection-of-antigenspecific-t-cell-lineages-and-effector-functions-based-on-secretory-signature-2/ 2019-07-10T14:24:38+00:00 https://www.pharmaceutical-business-review.com/news/nexus-injectable-manufacturing-wisconsin/attachment/nexus/ 2019-07-11T07:22:26+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-acquires-pre-clinical-pan-raf-inhibitor-program-from-redx-pharma/attachment/program/ 2019-07-11T08:12:28+00:00 https://www.pharmaceutical-business-review.com/products/command-center/attachment/resolver-command-center/ 2019-07-11T08:56:14+00:00 https://www.pharmaceutical-business-review.com/products/command-center/attachment/incident-performance-report/ 2019-07-11T08:56:44+00:00 https://www.pharmaceutical-business-review.com/products/command-center/attachment/srm-heatmap/ 2019-07-11T08:56:51+00:00 https://www.pharmaceutical-business-review.com/products/command-center/attachment/case-investigation/ 2019-07-11T08:57:00+00:00 https://www.pharmaceutical-business-review.com/products/command-center/attachment/corporate-security-brochure-1/ 2019-07-11T08:57:09+00:00 https://www.pharmaceutical-business-review.com/products/command-center/attachment/creating-a-business-case-for-security-software-1/ 2019-07-11T08:57:16+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcares-phase-3-study-of-dolutegravir-plus-lamivudine-meets-primary-endpoint/attachment/blood-20745_640/ 2019-07-11T10:50:26+00:00 https://www.pharmaceutical-business-review.com/suppliers/resolver/attachment/resolver-logo4/ 2019-07-11T13:52:30+00:00 https://www.pharmaceutical-business-review.com/suppliers/cbdepot/whitepapers/upmarket-cannabinoid-solutions/attachment/blog1/ 2019-07-11T15:02:45+00:00 https://www.pharmaceutical-business-review.com/suppliers/cbdepot/whitepapers/upmarket-cannabinoid-solutions/attachment/blog2/ 2019-07-11T15:02:48+00:00 https://www.pharmaceutical-business-review.com/news/novartis-amgen-alzheimers/attachment/novarbuilding/ 2019-07-12T07:00:15+00:00 https://www.pharmaceutical-business-review.com/news/sotio-initiates-first-in-human-clinical-trial-with-il-15-superagonist-so-c101/attachment/cancerparticle/ 2019-07-12T08:58:06+00:00 https://www.pharmaceutical-business-review.com/news/gilead-renown-institute-for-health-innovation-announce-collaboration-to-advance-understanding-of-nash/attachment/blood-17305_960_720/ 2019-07-12T10:48:42+00:00 https://www.pharmaceutical-business-review.com/suppliers/resolver/whitepapers/the-biggest-threats-to-pharmaceutical-companies/attachment/pbr-the-biggest-security-threats-to-pharmaceutical-companies_resolver/ 2019-07-12T15:31:43+00:00 https://www.pharmaceutical-business-review.com/news/gilead-galapagos-research-development/attachment/gilead-deal/ 2019-07-15T07:50:50+00:00 https://www.pharmaceutical-business-review.com/news/sensorion-receives-fda-ind-approval-for-arazasetron/attachment/fdadrug-29/ 2019-07-15T10:00:12+00:00 https://www.pharmaceutical-business-review.com/news/imfinzi-fda-orphan-drug-status-sclc/attachment/cq5dam-web-1200-az1572_equipment/ 2019-07-15T11:25:42+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-amal-therapeutics/attachment/boengher-4/ 2019-07-16T07:01:15+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-amal-therapeutics/attachment/boengherhd/ 2019-07-16T07:27:05+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-gets-breakthrough-therapy-designation-for-dcr-phxc-to-treat-primary-hyperoxaluria-type-1/attachment/fdadrug-30/ 2019-07-16T08:53:00+00:00 https://www.pharmaceutical-business-review.com/news/recordati-to-acquire-worldwide-rights-to-signifor-and-osilodrostat/attachment/tot-business-3167295_960_720/ 2019-07-16T11:07:34+00:00 https://www.pharmaceutical-business-review.com/news/novartis-crizanlizumab-priority-review/attachment/tower-with-logo-through-branches-image1/ 2019-07-17T06:52:33+00:00 https://www.pharmaceutical-business-review.com/news/zejula-prima-trial-results/attachment/22720111227_77ea5a925e_z/ 2019-07-17T07:30:37+00:00 https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/enclosed-ultrasonic-sieving-system/attachment/extract-tech-for-pbr/ 2019-07-17T09:49:20+00:00 https://www.pharmaceutical-business-review.com/suppliers/pharmabide-pharmaceutical-services/whitepapers/pharmacovigilance-regulatory-affairs/attachment/pharmabide-brochure/ 2019-07-17T09:58:38+00:00 https://www.pharmaceutical-business-review.com/news/kite-to-bolster-cell-therapy-manufacturing-capabilities-with-new-viral-vector-facility/attachment/cancer-cells-541954_960_720-10/ 2019-07-17T10:54:34+00:00 https://www.pharmaceutical-business-review.com/news/puretech-acquires-new-clinical-stage-programme-lyt-100-to-treat-lymphedema/attachment/lymph/ 2019-07-18T07:55:26+00:00 https://www.pharmaceutical-business-review.com/news/ahf-calls-on-gilead-to-set-up-fund-for-victims-harmed-by-its-tdf-based-drugs/attachment/law-1063249_960_720/ 2019-07-18T11:11:23+00:00 https://www.pharmaceutical-business-review.com/news/astellas-frequency-fx-322-deal/attachment/astellas-business-3167295_960_720/ 2019-07-18T12:05:28+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-bridge-biotherapeutics-ipf/attachment/boengherhd-2/ 2019-07-19T07:11:48+00:00 https://www.pharmaceutical-business-review.com/news/lifemax-receives-rare-pediatric-disease-designation-for-lm-030-to-treat-netherton-syndrome/attachment/usfdadevice-2/ 2019-07-19T11:12:08+00:00 https://www.pharmaceutical-business-review.com/news/merck-recarbrio-complicated-infections/attachment/fdadrug-31/ 2019-07-19T11:12:23+00:00 https://www.pharmaceutical-business-review.com/news/transgene-receives-mhra-approval-for-clinical-trial-of-next-generation-oncolytic-virus/attachment/virusparticle/ 2019-07-19T11:19:17+00:00 https://www.pharmaceutical-business-review.com/news/celgene-otezla-behcets-disease/attachment/fdadrug-32/ 2019-07-22T07:30:49+00:00 https://www.pharmaceutical-business-review.com/news/novartis-multiple-sclerosis-product-gilenya-approved-in-china/attachment/novartisdrug/ 2019-07-22T08:09:05+00:00 https://www.pharmaceutical-business-review.com/news/rising-pharmaceuticals-announces-the-us-launch-of-generic-version-of-pregabalin-capsules/attachment/medicine-2207622_960_720/ 2019-07-22T11:01:31+00:00 https://www.pharmaceutical-business-review.com/news/janssen-subcutaneous-use-daratumumab/attachment/darzalex-product-shot/ 2019-07-22T12:46:05+00:00 https://www.pharmaceutical-business-review.com/news/baxter-iv-insulin-myxredlin/attachment/ivinsulin/ 2019-07-23T07:03:21+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-recruits-first-patient-in-clinical-study-for-proposed-biosimilar-denosumab-in-osteoporosis/attachment/osteotrial/ 2019-07-23T07:55:21+00:00 https://www.pharmaceutical-business-review.com/news/acadia-announces-top-line-results-from-phase-3-schizophrenia-trial-of-pimavanserin/attachment/sc-laboratory-3827745_960_720/ 2019-07-23T11:18:18+00:00 https://www.pharmaceutical-business-review.com/news/viiv-fostemsavir-week-96-results/attachment/viiv-blood-17305_960_720/ 2019-07-23T11:56:01+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-roches-cancer-drug-rituxan/attachment/pfizer-11/ 2019-07-24T07:20:40+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-recalls-one-lot-of-drospirenone-and-ethinyl-estradiol-tablets/attachment/blister/ 2019-07-24T07:57:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/novo-nordisk-pharmatech/whitepapers/expisf9-cell-cultures/attachment/new-color_insect-novo-definitveversion-2/ 2019-07-24T08:03:36+00:00 https://www.pharmaceutical-business-review.com/casestudies/customized-pharmaceutical-sifting-machine-psl/attachment/psl-editorial-en-version/ 2019-07-24T08:07:49+00:00 https://www.pharmaceutical-business-review.com/news/ligand-acquires-ab-initio-biotherapeutics-an-antigen-discovery-company/attachment/ligand-handshake-3298455_960_720/ 2019-07-24T11:22:51+00:00 https://www.pharmaceutical-business-review.com/news/gemphire-therapeutics-and-neurobo-pharmaceuticals-announce-merger-agreement/attachment/merger/ 2019-07-25T08:08:34+00:00 https://www.pharmaceutical-business-review.com/news/bms-lung-cancer-opdivo/attachment/bmsfacility/ 2019-07-25T08:16:08+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-announces-positive-week-48-results-from-tango-study-of-dolutegravir-lamivudine/attachment/viv-blood-17305_960_720/ 2019-07-25T11:07:04+00:00 https://www.pharmaceutical-business-review.com/news/zambon-breath-therapeutics/attachment/zambon/ 2019-07-26T07:34:17+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-announces-fda-filing-acceptance-of-new-drug-application-and-priority-review-for-tazemetostat-to-treat-epithelioid-sarcoma/attachment/fdadrug-33/ 2019-07-26T08:51:51+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/attachment/enamine-logo/ 2019-07-26T10:45:09+00:00 https://www.pharmaceutical-business-review.com/news/verastem-signs-license-deal-with-sanofi-for-copiktra-in-certain-countries/attachment/mitosis-3876669_960_720-3/ 2019-07-26T11:16:23+00:00 https://www.pharmaceutical-business-review.com/news/tecentriq-chemotherapy-combo-chmp/attachment/roche-location-4/ 2019-07-29T08:14:59+00:00 https://www.pharmaceutical-business-review.com/news/ibm-kpmg-merck-and-walmart-to-assess-use-of-blockchain-to-protect-pharmaceutical-product-integrity/attachment/fdadrug-22/ 2019-07-29T11:17:14+00:00 https://www.pharmaceutical-business-review.com/news/alvotech-and-cipla-gulf-enter-into-a-partnership-for-the-commercialization-of-key-biosimilar-in-select-emerging-markets/attachment/cipla-business-3141342_960_720/ 2019-07-29T11:20:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/cf3-pyridine/attachment/enamine_analogues_of_cf3-pyridine_for_drug_design_2019/ 2019-07-29T13:51:35+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/cf3-pyridine/attachment/enamine_sugar-likebb_2019/ 2019-07-29T13:51:40+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/epoxides-drug-design/attachment/enamine_epoxides_for_drug_design_2019/ 2019-07-29T14:02:43+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/piperazine-bioisosteres-drug-design/attachment/enamine_piperazine-bioisosteres-2019/ 2019-07-29T14:03:04+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-upjohn-mylan/attachment/pfizerworld-11/ 2019-07-30T07:31:46+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-submits-regulatory-application-to-ema-for-investigational-cabotegravir-to-be-used-in-combination-with-rilpivirine-for-hiv/attachment/hiv-treat/ 2019-07-30T08:35:40+00:00 https://www.pharmaceutical-business-review.com/news/nec-acquires-norwegian-bioinformatics-company-oncoimmunity/attachment/nec-cancer-cells-541954_960_720/ 2019-07-30T11:06:58+00:00 https://www.pharmaceutical-business-review.com/news/springworks-nf1-treatment-mirdametinib/attachment/neuro-2/ 2019-07-31T07:48:14+00:00 https://www.pharmaceutical-business-review.com/news/verzenio-fulvestrant-monarch-2/attachment/800px-2006_0219firstfujifolder0012/ 2019-07-31T11:54:22+00:00 https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/custom-sanitary-circular-vibratory-screener/attachment/vibration/ 2019-07-31T15:29:59+00:00 https://www.pharmaceutical-business-review.com/news/bayer-prostate-cancer-nubeqa/attachment/bayer-nubeqa/ 2019-08-01T07:11:47+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-announces-closing-of-jv-with-gsk-to-create-premier-global-consumer-healthcare-company/attachment/pfizer-12/ 2019-08-01T08:00:49+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-aurigene-strike-deal-to-discover-and-develop-novel-therapies-for-cancer/attachment/cancer-cells-541954_960_720-11/ 2019-08-01T11:02:11+00:00 https://www.pharmaceutical-business-review.com/news/kisqali-fulvestrant-monaleesa-3/attachment/kisqali-product-and-packaging/ 2019-08-01T11:54:29+00:00 https://www.pharmaceutical-business-review.com/news/gsk-asthma-treatment-nucala/attachment/gsk-head-2/ 2019-08-02T07:36:34+00:00 https://www.pharmaceutical-business-review.com/news/alvogen-lotus-launch-generic-version-of-navelbine-softgel-capsule-in-europe/attachment/vino_launch/ 2019-08-02T08:16:10+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-kirin-buys-back-tivozanib-non-oncology-rights-from-aveo-oncology/attachment/kyowa-mitosis-3876669_960_720/ 2019-08-02T08:56:11+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-rivipansel-phase-3-scd/attachment/pfizerworldhead-3/ 2019-08-05T08:24:55+00:00 https://www.pharmaceutical-business-review.com/news/transgene-provides-update-on-phocus-study-of-pexa-vec-in-liver-cancer/attachment/liver-3306256_640/ 2019-08-05T09:26:27+00:00 https://www.pharmaceutical-business-review.com/news/antikor-biopharma-and-essex-bio-technology-forge-strategic-alliance-in-fdc-for-cancer-treatment/attachment/cancer-cells-541954_960_720-12/ 2019-08-05T10:53:28+00:00 https://www.pharmaceutical-business-review.com/contractors/lohmann-therapy-system-transdermal-therapeutic-systems-oral-thin-films/news/fire-truck-zichow-brigade/attachment/lts-uebernahme-feuerwehr-800x548/ 2019-08-05T11:55:40+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyos-turalio-fda/attachment/daiko-mitosis-3876669_960_720/ 2019-08-05T12:09:12+00:00 https://www.pharmaceutical-business-review.com/news/roches-tecentriq-chemotherapy-cancer/attachment/roche-1/ 2019-08-06T07:43:05+00:00 https://www.pharmaceutical-business-review.com/news/lilly-announces-positive-results-for-emgality-from-conquer-study/attachment/eli/ 2019-08-06T09:08:05+00:00 https://www.pharmaceutical-business-review.com/news/hcl-technologies-and-oracle-health-sciences-collaborate-to-accelerate-mhealth-in-clinical-trials/attachment/hcl_tech_noida_sez_campus/ 2019-08-06T10:58:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-givosiran-fda-priority-review/attachment/fda_bldg_51_-_main_entrance_5161374834-4/ 2019-08-06T11:40:53+00:00 https://www.pharmaceutical-business-review.com/news/aquinox-neoleukin-therapeutics/attachment/neoleukin/ 2019-08-07T07:14:55+00:00 https://www.pharmaceutical-business-review.com/news/ontario-provides-access-to-biktarvy-for-treatment-of-hiv/attachment/biktray/ 2019-08-07T08:07:47+00:00 https://www.pharmaceutical-business-review.com/casestudies/sanitary-circular-screener/attachment/klinge-pharma/ 2019-08-07T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-ebola-vaccines-sabin/attachment/brentford_-_980_great_west_road_middlesex_-_gsk_house_-_panoramio/ 2019-08-07T09:35:14+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-announces-acceptance-by-fda-of-nda-for-dasotraline-to-treat-binge-eating-disorder/attachment/fdadrug-34/ 2019-08-07T11:07:43+00:00 https://www.pharmaceutical-business-review.com/news/permira-small-molecule-cambrex/attachment/pemira/ 2019-08-08T07:48:37+00:00 https://www.pharmaceutical-business-review.com/news/lynparza-phase-iii-profound-trial-in-hrr-mutation-selected-metastatic-castration-resistant-prostate-cancer-met-primary-endpoint/attachment/lyparanza/ 2019-08-08T11:33:19+00:00 https://www.pharmaceutical-business-review.com/news/vesselon-acquires-fda-approved-lipid-microsphere-drug-imagent-for-therapeutic-platform/attachment/drugplat/ 2019-08-08T11:38:49+00:00 https://www.pharmaceutical-business-review.com/news/bayer-bluerock-therapeutics/attachment/bluerock/ 2019-08-09T07:42:09+00:00 https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-receives-fda-complete-response-letter-for-kpi-121-0-25-nda/attachment/dry-eye/ 2019-08-09T11:24:57+00:00 https://www.pharmaceutical-business-review.com/news/sesen-bio-reports-data-update-from-phase-3-trial-for-high-risk-non-muscle-invasive-bladder-cancer/attachment/blood/ 2019-08-09T11:31:38+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-tagrisso-lung-cancer/attachment/luncancer/ 2019-08-12T08:03:38+00:00 https://www.pharmaceutical-business-review.com/news/neoleukin-therapeutics-aquinox-pharmaceuticals-complete-merger-transaction/attachment/hand/ 2019-08-12T10:39:59+00:00 https://www.pharmaceutical-business-review.com/news/ascletis-opens-clinical-development-shanghai-center/attachment/syringe-1781353_960_720/ 2019-08-12T11:18:32+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-erelzi-patent-infringement/attachment/tower-with-surrounding-buildings-image1/ 2019-08-12T11:55:24+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-cavion/attachment/jazz/ 2019-08-13T07:53:14+00:00 https://www.pharmaceutical-business-review.com/news/eidos-therapeutics-confirms-receipt-of-non-binding-proposal-from-bridgebio-pharma-to-acquire-shares/attachment/bio/ 2019-08-13T10:21:25+00:00 https://www.pharmaceutical-business-review.com/news/kedrion-biopharma-announces-enrollment-of-first-patient-in-cares10-trial/attachment/lab-3498584_960_720/ 2019-08-13T10:58:12+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-anderson/attachment/siedziba_boehringer_ingelheim_w_polsce-2/ 2019-08-13T11:50:54+00:00 https://www.pharmaceutical-business-review.com/news/janssen-new-indications-ibrutinib/attachment/jandj-2/ 2019-08-14T08:07:22+00:00 https://www.pharmaceutical-business-review.com/news/landos-biopharma-completes-49-7m-series-b-financing/attachment/series-b/ 2019-08-14T09:03:10+00:00 https://www.pharmaceutical-business-review.com/casestudies/pharmaceutical-sieving-machine-granules/attachment/esteve/ 2019-08-15T14:09:12+00:00 https://www.pharmaceutical-business-review.com/news/roche-rozlytrek-ros1-nsclc/attachment/roche-7/ 2019-08-16T06:47:27+00:00 https://www.pharmaceutical-business-review.com/news/genecentric-therapeutics-acquires-select-immunogenomics/attachment/gle/ 2019-08-16T08:11:50+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-validates-marketing-application-for-filgotinib-for-the-treatment-of-rheumatoid-arthritis/attachment/rheumatoid_arthritis/ 2019-08-16T08:45:25+00:00 https://www.pharmaceutical-business-review.com/news/celgene-myelofibrosis-inrebic/attachment/fdadrug-35/ 2019-08-19T08:14:40+00:00 https://www.pharmaceutical-business-review.com/news/xynomic-research-institute-successfully-designs-series-of-potent-ret-kinase-inhibitors/attachment/pharmadrug-2/ 2019-08-19T10:53:02+00:00 https://www.pharmaceutical-business-review.com/news/fda-moderna-zika-vaccine/attachment/zika/ 2019-08-20T07:10:41+00:00 https://www.pharmaceutical-business-review.com/news/angel-funded-siamab-completes-166m-exit-with-large-commercial-stage-biopharma/attachment/virus-9/ 2019-08-20T07:49:47+00:00 https://www.pharmaceutical-business-review.com/news/knopp-begins-phase-2-trial-for-oral-dexpramipexole-in-eosinophilic-asthma/attachment/knopptest-214185_960_720/ 2019-08-20T10:34:24+00:00 https://www.pharmaceutical-business-review.com/news/sanfer-cdpq-investment/attachment/sanfer-agreement-3489902_960_720/ 2019-08-20T12:15:17+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-farxiga-heart-failure/attachment/tarixga/ 2019-08-21T06:52:11+00:00 https://www.pharmaceutical-business-review.com/news/bayer-animal-health-elanco/attachment/2014-9661/ 2019-08-21T10:39:05+00:00 https://www.pharmaceutical-business-review.com/news/graybug-vision-secures-66m-to-advance-retina-and-glaucoma-clinical-programs/attachment/risk-str-business-3167295_960_720/ 2019-08-21T10:44:59+00:00 https://www.pharmaceutical-business-review.com/news/gsk-submits-first-regulatory-application-for-daprodustat-in-japan/attachment/gsk-head-3/ 2019-08-22T08:29:53+00:00 https://www.pharmaceutical-business-review.com/news/oncorus-series-b-funding/attachment/onco-mitosis-3876669_960_720/ 2019-08-22T10:32:26+00:00 https://www.pharmaceutical-business-review.com/news/cabotegravir-rilpivirine-atlas-2m/attachment/hiv-1903372_960_720/ 2019-08-23T06:19:24+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-new-drug-application-for-elexacaftor-tezacaftor-and-ivacaftor-combination-treatment/attachment/fdadrug-36/ 2019-08-23T10:43:20+00:00 https://www.pharmaceutical-business-review.com/news/finch-raises-43m-to-advance-microbiome-based-therapies-for-recurrent-cdi-autism-and-other-disease-areas/attachment/finch-business-3167295_960_720/ 2019-08-23T10:48:07+00:00 https://www.pharmaceutical-business-review.com/news/gilead-galapagos-deal-closing/attachment/gil-business-3152586_960_720/ 2019-08-26T04:11:13+00:00 https://www.pharmaceutical-business-review.com/news/beyondsprings-plinabulin-demonstrates-superior-quality-of-life-in-phase-2-3-study-in-neutropenia/attachment/beyond-red-blood-cells-3188223_960_720/ 2019-08-26T04:20:35+00:00 https://www.pharmaceutical-business-review.com/news/belantamab-mafodotin-multiple-myeloma/attachment/gsk-head-4/ 2019-08-26T05:26:48+00:00 https://www.pharmaceutical-business-review.com/news/cantargia-biowa-extend-ongoing-collaboration-around-potelligent-technology/attachment/drug-10/ 2019-08-26T06:54:47+00:00 https://www.pharmaceutical-business-review.com/news/adc-therapeutics-and-freenome-enter-biomarker-development-collaboration/attachment/tumor-5/ 2019-08-27T07:24:48+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-appeal-opioid-judgment-in-oklahoma/attachment/1024px-johnsonjohnson_hq_building/ 2019-08-27T08:20:50+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lilly-taltz/attachment/1024px-eli_lilly_corporate_center_indianapolis_indiana_usa/ 2019-08-27T11:07:05+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-acquire-modis-therapeutics/attachment/dna-1811955_960_720/ 2019-08-28T05:10:36+00:00 https://www.pharmaceutical-business-review.com/news/onconano-awarded-12-6m-grant-from-cancer-prevention-and-research-institute-of-texas/attachment/onco-cancer-cells-541954_960_720/ 2019-08-28T11:13:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/ecommerce-services-chemical-products/attachment/news-posts-enamine/ 2019-08-28T14:27:18+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/responsible-person-course-mhra/attachment/print-5/ 2019-08-28T15:54:52+00:00 https://www.pharmaceutical-business-review.com/news/immatics-celgene-cancer-immunotherapies/attachment/cel-mitosis-3876669_960_720/ 2019-08-29T05:37:10+00:00 https://www.pharmaceutical-business-review.com/news/hifibio-therapeutics-closes-55m-series-c-financing/attachment/integrity-agreement-3489902_960_720/ 2019-08-29T10:47:26+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-fasenra-eoe-odd/attachment/astrazeneca-hq-10/ 2019-08-29T12:46:36+00:00 https://www.pharmaceutical-business-review.com/news/roche-tecentriq-abraxane/attachment/roche-1-2/ 2019-08-30T08:04:30+00:00 https://www.pharmaceutical-business-review.com/news/springworks-therapeutics-gets-breakthrough-therapy-designation-for-nirogacestat-to-treat-desmoid-tumours/attachment/fdadrug-37/ 2019-08-30T10:41:20+00:00 https://www.pharmaceutical-business-review.com/news/venatorx-initiates-enrollment-in-phase-3-trial-of-cefepime-vnrx-5133-in-cutis/attachment/ven-medic-563423_960_720/ 2019-08-30T10:59:10+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-anifrolumab-sle/attachment/tarixga-1024x686/ 2019-08-30T12:20:07+00:00 https://www.pharmaceutical-business-review.com/news/novartis-ofatumumab-rms-trials/attachment/tower-with-surrounding-buildings-image1-2/ 2019-08-30T12:37:06+00:00 https://www.pharmaceutical-business-review.com/suppliers/source-bioscience/attachment/cryobank/ 2019-09-02T11:04:42+00:00 https://www.pharmaceutical-business-review.com/suppliers/source-bioscience/attachment/cryobank2/ 2019-09-02T11:06:48+00:00 https://www.pharmaceutical-business-review.com/suppliers/source-bioscience/attachment/technician_working-pipette-cropped/ 2019-09-02T11:06:55+00:00 https://www.pharmaceutical-business-review.com/suppliers/source-bioscience/attachment/jpeg-version/ 2019-09-02T11:07:40+00:00 https://www.pharmaceutical-business-review.com/suppliers/source-bioscience/attachment/stability-suite/ 2019-09-02T11:09:22+00:00 https://www.pharmaceutical-business-review.com/news/roche-xofluza-flu-study/attachment/roche-1-3/ 2019-09-03T07:32:41+00:00 https://www.pharmaceutical-business-review.com/news/valbiotis-announces-additional-positive-results-from-phase-iia-clinical-study-of-valedia/attachment/tablet-7/ 2019-09-03T08:22:11+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/benzoxaboroles-drug-design/attachment/benzoxaboroles/ 2019-09-03T08:31:42+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/principles-haccp/attachment/wa4337-applying-principles-of-haccp-whitepaper-aug19-final/ 2019-09-03T08:47:50+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/analytical-tools-li-ion-batteries/attachment/wp21cfr_xrf/ 2019-09-03T10:59:39+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/analytical-tools-li-ion-batteries/attachment/ar181205analyticalsolutionsbatteries/ 2019-09-03T11:02:25+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/whitepapers/characterisation-liposomes-complementary/attachment/wpthroughcharacterizationofliposomes/ 2019-09-03T11:06:10+00:00 https://www.pharmaceutical-business-review.com/news/insilico-medicine-gentrl-ai/attachment/artificial-intelligence-3382507_960_720-3/ 2019-09-03T12:07:32+00:00 https://www.pharmaceutical-business-review.com/news/deals/vertex-acquire-semma-therapeutics/attachment/stem-business-3167295_960_720/ 2019-09-04T06:08:09+00:00 https://www.pharmaceutical-business-review.com/news/impel-neuropharma-enrolls-last-patient-in-phase-3-migraine-trial-of-inp104/attachment/impel-science-1029385_960_720/ 2019-09-04T11:06:05+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-lupin-deal/attachment/bic_flagge/ 2019-09-04T11:57:52+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/principles-haccp/attachment/want-to-become-a-better-auditor-v1-converted/ 2019-09-05T08:18:32+00:00 https://www.pharmaceutical-business-review.com/news/maruho-and-x-chem-announce-drug-discovery-collaboration/attachment/maruho-handshake-3298455_960_720/ 2019-09-05T11:11:23+00:00 https://www.pharmaceutical-business-review.com/news/sumitomo-dainippon-roivant-alliance/attachment/dainippon_sumitomo_pharma/ 2019-09-06T06:15:15+00:00 https://www.pharmaceutical-business-review.com/news/veralox-therapeutics-raises-5-4m-in-seed-funding-co-led-by-jdrf-t1d-fund-and-sanofi-ventures/attachment/vera-business-3152586_960_720/ 2019-09-06T11:04:21+00:00 https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/circular-vibratory-screeners/attachment/chemical-screeners-for-pbr/ 2019-09-06T11:32:09+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheims-ofev-ssc-ild-fda/attachment/3381a524-6b8f-4416-a14c-5f3db6b3f457/ 2019-09-09T10:19:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-imfinzi/attachment/farinzo/ 2019-09-10T07:08:01+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-imfinzi/attachment/astr/ 2019-09-10T07:10:59+00:00 https://www.pharmaceutical-business-review.com/news/esketamine-nasal-spray-aspire/attachment/janssen-spravato-nasal-spray-2/ 2019-09-10T10:12:04+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-gets-fda-orphan-drug-designation-for-sotatercept-in-pulmonary-arterial-hypertension/attachment/fdadrug-38/ 2019-09-10T10:26:21+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/silicon-containing-building-blocks/attachment/wp_09-09/ 2019-09-10T12:40:13+00:00 https://www.pharmaceutical-business-review.com/products/on-site-biological-screening/attachment/bienta_cat-19/ 2019-09-10T13:06:15+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-biovectra/attachment/baxter/ 2019-09-11T07:54:53+00:00 https://www.pharmaceutical-business-review.com/news/avalon-ventures-and-coi-pharmaceuticals-announce-acquisition-of-sitari-pharmaceuticals-by-gsk/attachment/gsk-5/ 2019-09-11T09:22:18+00:00 https://www.pharmaceutical-business-review.com/news/xeris-gvoke-severe-hypoglycaemia/attachment/fda_bldg_51_-_main_entrance_5161374834-5/ 2019-09-11T10:06:59+00:00 https://www.pharmaceutical-business-review.com/news/merck-initiates-phase-3-programme-for-evobrutinib-in-relapsing-multiple-sclerosis/attachment/merck-test-214185_960_720/ 2019-09-11T10:24:21+00:00 https://www.pharmaceutical-business-review.com/news/roches-tecentriq-lung-cancer-2/attachment/roche-1-4/ 2019-09-12T07:40:58+00:00 https://www.pharmaceutical-business-review.com/news/hansoh-pharma-atomwise-launch-ai-drug-discovery-collaboration-for-multiple-therapeutic-areas/attachment/phar/ 2019-09-12T10:21:05+00:00 https://www.pharmaceutical-business-review.com/news/vbi-vaccines-announces-phase-2a-trial-of-vbi-1901-cancer-vaccine-candidate-in-combination-with-as01b-adjuvant-system-in-recurrent-glioblastoma-patients/attachment/blood-20745_960_720-2/ 2019-09-12T10:48:15+00:00 https://www.pharmaceutical-business-review.com/suppliers/malvern__instruments__particle__size__analysis__measurement__solutions/attachment/mp_spectris_logo_rgb-002/ 2019-09-12T14:53:20+00:00 https://www.pharmaceutical-business-review.com/news/fda-gsk-nucala-asthma/attachment/gsk-house-4/ 2019-09-13T07:07:43+00:00 https://www.pharmaceutical-business-review.com/news/aytu-bioscience-to-acquire-innovus-pharmaceuticals/attachment/pharacq/ 2019-09-13T09:02:31+00:00 https://www.pharmaceutical-business-review.com/news/celgenes-quazar-aml-001-trial-of-cc-486-meets-primary-and-key-secondary-endpoints/attachment/cel-cancer-cells-541954_960_720/ 2019-09-13T10:48:54+00:00 https://www.pharmaceutical-business-review.com/news/novartis-rms-ofatumumab/attachment/novartistower-2/ 2019-09-14T06:14:34+00:00 https://www.pharmaceutical-business-review.com/news/ctd-holdings-announces-fda-approval-of-us-expanded-access-treatment-program-in-niemann-pick-disease-type-c/attachment/fdadrug-39/ 2019-09-16T10:15:31+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-presents-initial-top-line-clinical-data-and-preclinical-data-on-rnai-candidates-aro-apoc3-and-aro-ang3/attachment/science-1336663_960_720/ 2019-09-16T10:42:53+00:00 https://www.pharmaceutical-business-review.com/news/aimmune-peanut-allergy-drug-fda/attachment/aim-nuts-1736520_960_720/ 2019-09-16T13:25:44+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-alder-biopharmaceuticals/attachment/lundbeck-2/ 2019-09-17T07:22:24+00:00 https://www.pharmaceutical-business-review.com/news/accenture-announces-collaboration-with-bayer-to-streamline-drug-development-processes-through-intient-clinical-platform/attachment/drug-11/ 2019-09-17T07:56:33+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-fda-heart-failure/attachment/astrazeneca-hq-11/ 2019-09-17T10:09:51+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-initiates-apollo-b-phase-3-study-of-patisiran-for-treatment-of-transthyretin-amyloidosis-with-cardiomyopathy/attachment/aln-science-1029385_960_720/ 2019-09-17T10:17:32+00:00 https://www.pharmaceutical-business-review.com/news/fkeytruda-lenvima-endometrial-carcinoma/attachment/keytruda-3/ 2019-09-18T07:18:09+00:00 https://www.pharmaceutical-business-review.com/news/poxel-initiates-phase-1b-multiple-ascending-dose-trial-for-nash-drug-candidate/attachment/poxel/ 2019-09-18T08:07:28+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-completes-enrollment-in-second-open-label-trial-of-ctp-543-in-alopecia-areata/attachment/test-214185_960_720/ 2019-09-18T10:48:15+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-prevent-trial/attachment/novartis-tower-with-logo-image/ 2019-09-18T12:46:12+00:00 https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/multi-deck-hygienic-sifter/attachment/pharma-sieve/ 2019-09-18T13:33:10+00:00 https://www.pharmaceutical-business-review.com/news/roche-gazyva-lupus-nephritis/attachment/rochebuilding/ 2019-09-19T07:06:30+00:00 https://www.pharmaceutical-business-review.com/news/graybug-vision-initiates-clinical-trial-in-macular-edema-secondary-to-diabetic-macular-edema-or-retinal-vein-occlusion/attachment/retina/ 2019-09-19T08:19:01+00:00 https://www.pharmaceutical-business-review.com/news/sanbio-rmat-sb623-cell-therapy/attachment/fdadrug-40/ 2019-09-19T13:17:35+00:00 https://www.pharmaceutical-business-review.com/news/pifeltro-delstrigo-hiv-1/attachment/fdadrug-41/ 2019-09-23T07:42:46+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-to-treat-fatty-acid-oxidation-disorders/attachment/pharm/ 2019-09-23T10:37:34+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gene-therapy-facility/attachment/pfizerworld-2-2/ 2019-09-23T11:27:39+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-inflammasome/attachment/800px-siedziba_boehringer_ingelheim_w_polsce-3/ 2019-09-23T13:07:21+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/heterocyclic-sulfonyl-fluorides/attachment/190909_rso2f_hal_ed/ 2019-09-23T14:01:14+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/unnatural-amino-acids/attachment/unnatural-amino/ 2019-09-23T14:09:24+00:00 https://www.pharmaceutical-business-review.com/news/annexons-guillain-barre-syndrome/attachment/fdadrug-42/ 2019-09-24T07:30:09+00:00 https://www.pharmaceutical-business-review.com/news/clovis-oncology-acquires-rights-to-fap-targeted-radiopharmaceutical-programme-from-3b-pharmaceuticals/attachment/clovis/ 2019-09-24T09:53:53+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-announces-positive-results-from-engage-study-of-dysport-combo-with-gsc-in-adults-with-upper-and-lower-limb-spastic-hemiparesis/attachment/ipsen-science-1336663_960_720/ 2019-09-24T10:30:24+00:00 https://www.pharmaceutical-business-review.com/news/cerevels-tavapadon-phase-2-trial/attachment/cere-laboratory-3827743_960_720/ 2019-09-24T12:19:57+00:00 https://www.pharmaceutical-business-review.com/contractors/malvern__instruments__particle__size__analysis__measurement__solutions/news/collaboration-university-bristol/attachment/malvern_panalytical_010/ 2019-09-24T13:12:06+00:00 https://www.pharmaceutical-business-review.com/news/zealands-pharma-dasiglucagon/attachment/autoinjector/ 2019-09-25T07:26:19+00:00 https://www.pharmaceutical-business-review.com/news/aldeyra-therapeutics-receives-fast-track-designation-for-adx-2191-for-prevention-of-proliferative-vitreoretinopathy/attachment/fdadrug-43/ 2019-09-25T08:05:01+00:00 https://www.pharmaceutical-business-review.com/news/amphivena-closes-62m-series-c-financing-to-expand-clinical-development-of-amv564-into-solid-tumors-and-to-develop-t-cell-engagement-portfolio/attachment/tip-agreement-3489902_960_720/ 2019-09-25T10:54:45+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-flatiron-health-collaboration/attachment/pfizerworldheadquartersentrance-5/ 2019-09-25T11:44:24+00:00 https://www.pharmaceutical-business-review.com/news/jazzs-jzp-258-narcolepsy-trial/attachment/jazz-2/ 2019-09-26T07:44:49+00:00 https://www.pharmaceutical-business-review.com/news/blade-therapeutics-expands-anti-fibrotic-pipeline-with-acquisition-of-atxco-and-its-autotaxin-inhibitor/attachment/autoxin/ 2019-09-26T09:47:30+00:00 https://www.pharmaceutical-business-review.com/news/incyte-announces-first-patient-treated-in-phase-3-trial-program-evaluating-ruxolitinib-cream-in-patients-with-vitiligo/attachment/incy-laboratory-3827743_960_720/ 2019-09-26T10:39:13+00:00 https://www.pharmaceutical-business-review.com/news/noveome-biotherapeutics-initiates-trial-evaluating-intranasal-delivery-of-st266-targeting-optic-nerve-and-brain/attachment/braincandid/ 2019-09-27T08:34:36+00:00 https://www.pharmaceutical-business-review.com/news/samsung-bioepis-announces-phase-3-results-of-sb8-bevacizumab-biosimilar-candidate-at-esmo-2019-congress/attachment/samsung-mitosis-3876669_960_720/ 2019-09-27T11:14:05+00:00 https://www.pharmaceutical-business-review.com/suppliers/n-side/attachment/aggregated-budget/ 2019-09-27T14:44:34+00:00 https://www.pharmaceutical-business-review.com/suppliers/n-side/attachment/dashboard-monitoring/ 2019-09-27T14:50:13+00:00 https://www.pharmaceutical-business-review.com/products/medchem-highlights/attachment/medchem/ 2019-09-27T14:51:23+00:00 https://www.pharmaceutical-business-review.com/suppliers/n-side/attachment/n-side-logo/ 2019-09-27T15:47:01+00:00 https://www.pharmaceutical-business-review.com/news/roche-rituxan-blood-vessel/attachment/rochebuild-2/ 2019-09-30T08:00:16+00:00 https://www.pharmaceutical-business-review.com/news/tagrisso-is-only-first-line-treatment-for-egfr-mutated-nsclc-to-deliver-median-overall-survival-of-over-three-years/attachment/astra-2/ 2019-09-30T08:46:35+00:00 https://www.pharmaceutical-business-review.com/news/clover-biopharmaceuticals-doses-first-patient-in-phase-i-study-of-scb-313-in-china-for-malignant-ascites/attachment/clover-lab-3498584_960_720/ 2019-09-30T11:33:53+00:00 https://www.pharmaceutical-business-review.com/news/gsks-niraparib-prima-trial/attachment/22720111227_77ea5a925e_z-2/ 2019-09-30T13:06:51+00:00 https://www.pharmaceutical-business-review.com/news/sobi-dova-pharmaceuticals/attachment/sobi/ 2019-10-01T07:54:10+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-to-launch-temixys-double-combination-once-daily-tablet-for-hiv-treatment-in-us/attachment/temix/ 2019-10-01T09:32:24+00:00 https://www.pharmaceutical-business-review.com/news/restore-imi-2-phase-3-study-of-mercks-recarbrio-in-habp-vabp-meets-primary-endpoint/attachment/msd-test-tubes-1-1494460/ 2019-10-01T11:32:10+00:00 https://www.pharmaceutical-business-review.com/news/servier-pixuvri-cti-biopharma/attachment/red-blood-cell-4256710_960_720/ 2019-10-01T13:26:07+00:00 https://www.pharmaceutical-business-review.com/news/lantheus-progenics-pharmaceuticals/attachment/lantheus/ 2019-10-03T07:39:57+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-approved-as-monotherapy-in-china-for-first-line-treatment-of-certain-patients-with-advanced-nsclc/attachment/keytruda-100mg-4ml-vial-and-carton-4/ 2019-10-03T09:51:11+00:00 https://www.pharmaceutical-business-review.com/news/elicio-therapeutics-completes-33m-series-b-financing/attachment/q2-business-3167295_960_720/ 2019-10-03T10:34:33+00:00 https://www.pharmaceutical-business-review.com/news/gsk-trelegy-ellipta-asthma/attachment/800px-glaxosmithkline_3_franklin_plaza_philadelphia/ 2019-10-03T11:42:52+00:00 https://www.pharmaceutical-business-review.com/news/gilead-hiv-prep-drug-descovy/attachment/hiv-drug/ 2019-10-04T07:06:43+00:00 https://www.pharmaceutical-business-review.com/news/goldfinch-bio-takeda-sign-deal-for-cb1-monoclonal-antibody-to-treat-rare-and-metabolic-kidney-diseases/attachment/takeda-3/ 2019-10-04T07:58:35+00:00 https://www.pharmaceutical-business-review.com/news/icosavax-launches-with-51m-series-a-financing-to-advance-computationally-designed-vlp-vaccines/attachment/tokio-business-3141342_960_720/ 2019-10-04T08:32:31+00:00 https://www.pharmaceutical-business-review.com/news/dbv-technologies-announces-fda-acceptance-of-bla-filing-for-viaskin-peanut-to-treat-peanut-allergy/attachment/fdadrug-45/ 2019-10-07T09:28:39+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-invest-500m-to-end-hiv-and-tuberculosis/attachment/jjbuilding-2/ 2019-10-07T09:31:02+00:00 https://www.pharmaceutical-business-review.com/news/pfenex-pf708-osteoporosis/attachment/fda_bldg_51_-_main_entrance_5161374834-6/ 2019-10-07T13:00:11+00:00 https://www.pharmaceutical-business-review.com/news/novartis-beovu-wet-amd-fda/attachment/beovu/ 2019-10-09T08:26:52+00:00 https://www.pharmaceutical-business-review.com/news/hoth-therapeutics-completes-phase-1-of-in-life-dose-escalation-study-for-treating-eczema/attachment/hoth-science-1336663_960_720/ 2019-10-09T11:24:59+00:00 https://www.pharmaceutical-business-review.com/news/ideaya-announces-first-patient-dosing-of-ide196-for-solid-tumors-outside-of-uveal-melanoma/attachment/ide-mitosis-3876669_960_720/ 2019-10-09T11:31:38+00:00 https://www.pharmaceutical-business-review.com/news/viela-mitsubishi-tanabe-inebilizumab/attachment/800px-mitsubishi_tanabe_pharma/ 2019-10-10T07:25:03+00:00 https://www.pharmaceutical-business-review.com/news/nsf-international-amarex-cro/attachment/cro/ 2019-10-10T07:34:58+00:00 https://www.pharmaceutical-business-review.com/news/dermira-begins-phase-3-programme-to-assess-lebrikizumab-in-patients-with-moderate-to-severe-atopic-dermatitis/attachment/derma/ 2019-10-10T09:14:17+00:00 https://www.pharmaceutical-business-review.com/news/ionis-factor-xi-anti-thrombotic-medicine-advances-with-bayer-following-positive-clinical-results/attachment/red-blood-cell-4216070_960_720/ 2019-10-10T10:05:14+00:00 https://www.pharmaceutical-business-review.com/news/akcea-to-license-investigative-antisense-therapy-akcea-angptl3-lrx-to-pfizer/attachment/pfizerworldheadquartersentrance-6/ 2019-10-10T10:31:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/azide-linkers-for-drug-design/attachment/enamine-azides-2018/ 2019-10-10T16:05:54+00:00 https://www.pharmaceutical-business-review.com/contractors/russell__finex__fine__mesh__separation__technology/news/particle-separation-powders-multi-deck-separator/attachment/multideck-separator-for-pharma-pbr/ 2019-10-11T08:35:39+00:00 https://www.pharmaceutical-business-review.com/news/alexion-stealth-announce-agreement-for-option-to-co-develop-and-commercialise-late-stage-therapy-for-mitochondrial-diseases/attachment/mitochondria/ 2019-10-11T09:30:59+00:00 https://www.pharmaceutical-business-review.com/news/ucb-ra-pharmaceuticals/attachment/ucb/ 2019-10-11T10:10:30+00:00 https://www.pharmaceutical-business-review.com/news/gilead-galapagos-announce-52-week-results-of-filgotinib-in-finch-1-finch-3-studies-in-rheumatoid-arthritis/attachment/gil-test-214185_960_720/ 2019-10-11T10:49:09+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-migraine-reyvow/attachment/lilli/ 2019-10-14T07:47:06+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-launches-cequa-for-treatment-of-dry-eye-disease-in-us/attachment/dry-eye-2/ 2019-10-14T09:10:02+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-presents-positive-phase-3-data-for-abrocitinib-in-moderate-to-severe-atopic-dermatitis/attachment/pfizerworldheadquartersentrance-7/ 2019-10-14T10:21:49+00:00 https://www.pharmaceutical-business-review.com/news/mabthera-pemphix-trial-pemphigus-vulgaris/attachment/roche-location-5/ 2019-10-14T12:18:13+00:00 https://www.pharmaceutical-business-review.com/news/janssen-bayer-xarelto-vte/attachment/bayer_berlin/ 2019-10-15T08:10:08+00:00 https://www.pharmaceutical-business-review.com/news/forbius-completes-enrollment-into-phase-1a-solid-tumour-trial-of-avid200/attachment/tumor-6/ 2019-10-15T09:11:26+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-kirin-launches-nourianz-in-us-for-treatment-of-parkinsons-disease-off-episodes/attachment/thermometer-1539191_960_720/ 2019-10-15T10:59:54+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-ionicx-xrf-analyzer/attachment/newsroom-photos-company-1/ 2019-10-15T11:52:47+00:00 https://www.pharmaceutical-business-review.com/news/acino-takeda-prescription-pharmaceutical/attachment/takeda-build/ 2019-10-16T07:53:31+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-launches-drizalma-sprinkle-in-us/attachment/capsule/ 2019-10-16T09:37:55+00:00 https://www.pharmaceutical-business-review.com/news/trialbee-and-trinetx-partner-to-accelerate-patient-centric-clinical-trials/attachment/hospital-3089884_960_720/ 2019-10-16T10:13:07+00:00 https://www.pharmaceutical-business-review.com/news/crispr-ksq-therapeutics-cell-therapies/attachment/ksq-dna-1903318_960_720/ 2019-10-16T10:46:39+00:00 https://www.pharmaceutical-business-review.com/news/alexion-biopharmaceutical-firm-achillion/attachment/alexion-2/ 2019-10-17T06:55:39+00:00 https://www.pharmaceutical-business-review.com/news/tripharm-services-announces-creation-of-pharmaceutical-manufacturing-center/attachment/tripharm/ 2019-10-17T09:19:31+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-enrols-first-patient-in-phase-ii-balance-cftm-1-study/attachment/medic-563423_6401/ 2019-10-17T09:48:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/emballiso-pharma-br-storefront/attachment/emballiso-network/ 2019-10-17T14:07:42+00:00 https://www.pharmaceutical-business-review.com/suppliers/emballiso-pharma-br-storefront/attachment/pallet-shipper/ 2019-10-17T14:07:49+00:00 https://www.pharmaceutical-business-review.com/suppliers/emballiso-pharma-br-storefront/attachment/reverse-logistics-business-model/ 2019-10-17T14:07:54+00:00 https://www.pharmaceutical-business-review.com/suppliers/emballiso-pharma-br-storefront/attachment/logo_fond_bleu2/ 2019-10-17T14:23:13+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/deep-freeze/ 2019-10-17T14:37:31+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/emballiso-range-of-product/ 2019-10-17T14:37:39+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/isogo/ 2019-10-17T14:37:54+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/isothermal-bags/ 2019-10-17T14:38:02+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/pallet-shipper-2/ 2019-10-17T14:38:16+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/tlx-by-emball-iso/ 2019-10-17T14:38:30+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/vype/ 2019-10-17T14:38:36+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/pallet-shipper-flat-packed/ 2019-10-17T14:39:22+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/high-performance-box-pallet-ouvert/ 2019-10-17T14:54:21+00:00 https://www.pharmaceutical-business-review.com/products/pallet-shipper/attachment/box-pallet-2/ 2019-10-17T14:54:24+00:00 https://www.pharmaceutical-business-review.com/products/box-pallet/attachment/box-pallet-lead/ 2019-10-17T14:56:32+00:00 https://www.pharmaceutical-business-review.com/suppliers/emballiso-pharma-br-storefront/attachment/pallet2/ 2019-10-17T15:53:36+00:00 https://www.pharmaceutical-business-review.com/news/horizon-therapeutics-initiates-protect-clinical-trial-of-krystexxa-pegloticase-injection/attachment/biology-220005_640/ 2019-10-18T09:09:17+00:00 https://www.pharmaceutical-business-review.com/news/trastuzumab-deruxtecan-granted-fda-priority-review-to-treat-patients-with-her2-positive-metastatic-breast-cancer/attachment/astra-3/ 2019-10-18T10:28:43+00:00 https://www.pharmaceutical-business-review.com/news/horizon-therapeutics-initiates-protect-clinical-trial-of-krystexxa-pegloticase-injection/attachment/test-214185_640/ 2019-10-18T10:33:34+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-gsk/attachment/gsk-house-5/ 2019-10-21T08:12:52+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/amarex-cro/attachment/kazem_250x250/ 2019-10-21T10:36:40+00:00 https://www.pharmaceutical-business-review.com/news/verseau-launches-with-50m-to-develop-first-in-class-macrophage-targeted-immunotherapies/attachment/rop-agreement-3489902_960_720/ 2019-10-21T10:56:56+00:00 https://www.pharmaceutical-business-review.com/news/deals/sartorius-stedim-danaher-deal/attachment/rop-agreement-3489902_960_720-2/ 2019-10-21T11:52:37+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-farxiga-heart-failure/attachment/astra-4/ 2019-10-22T07:48:32+00:00 https://www.pharmaceutical-business-review.com/contractors/novo-nordisk-pharmatech/news/branch-office-singapore/attachment/img_0332/ 2019-10-22T09:09:26+00:00 https://www.pharmaceutical-business-review.com/news/odonate-therapeutics-announces-completion-of-enrollment-in-contessa-metastatic-breast-cancer-trial/attachment/meta/ 2019-10-22T09:36:48+00:00 https://www.pharmaceutical-business-review.com/news/deals/knight-therapeutics-acquire-biotoscana/attachment/knibusiness-3167295_960_720/ 2019-10-22T10:59:13+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-trikafta-to-treat-the-underlying-cause-of-cystic-fibrosis/attachment/knibusiness-3167295_960_720-2/ 2019-10-22T11:04:55+00:00 https://www.pharmaceutical-business-review.com/news/moderna-propionic-acidemia/attachment/fdadrug-47/ 2019-10-23T06:27:40+00:00 https://www.pharmaceutical-business-review.com/news/zealand-pharma-expands-peptide-platform-with-acquisition-of-encycle-therapeutics/attachment/zealand/ 2019-10-23T09:31:54+00:00 https://www.pharmaceutical-business-review.com/news/cyclo-therapeutics-completes-enrollment-in-phase-1-trial-to-evaluate-trappsol-cyclo-for-the-treatment-of-niemann-pick-disease-type-c/attachment/cyclotest-214185_960_720/ 2019-10-23T10:57:45+00:00 https://www.pharmaceutical-business-review.com/news/takeda-tak-101-license-cour/attachment/800px-takeda_pharmaceutical_company_tokyo_head_office_1/ 2019-10-23T11:31:42+00:00 https://www.pharmaceutical-business-review.com/news/gsk-ovarian-cancer-zejula/attachment/gsk-6/ 2019-10-24T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/talaris-therapeutics-initiates-phase-3-clinical-trial-of-fcr001-in-living-donor-kidney-transplant-recipients/attachment/humankidney/ 2019-10-24T09:27:58+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/cphi-worldwide-2019/attachment/team-cphi/ 2019-10-24T10:12:45+00:00 https://www.pharmaceutical-business-review.com/news/rapt-therapeutics-announces-initiation-of-first-in-human-phase-1-study-of-rpt193/attachment/rscience-1336663_960_720/ 2019-10-24T10:47:24+00:00 https://www.pharmaceutical-business-review.com/news/bms-melanoma-drug-opdivo/attachment/bmsfacility-2/ 2019-10-25T07:26:29+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/your-free-pqs-health-check/attachment/nsf-pb-white-paper-your-free-pqs-health-check/ 2019-10-25T09:27:39+00:00 https://www.pharmaceutical-business-review.com/news/avrobio-receives-orphan-drug-designation-from-fda-for-avr-rd-02-to-treat-gaucher-disease/attachment/fdadrug-48/ 2019-10-25T09:36:50+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-pharmaceuticals-announces-submission-to-fda-of-updated-bla-for-rolontis/attachment/mitosis-3876669_960_720-4/ 2019-10-25T10:25:33+00:00 https://www.pharmaceutical-business-review.com/news/astellas-gilteritinib-ec-approval-aml/attachment/asmitosis-3876669_960_720/ 2019-10-28T09:10:23+00:00 https://www.pharmaceutical-business-review.com/news/lipac-oncology-announces-successful-completion-of-phase-1-bladder-cancer-clinical-study-and-initiation-of-phase-2a-study/attachment/lipac-cancer-cells-541954_960_720/ 2019-10-28T10:57:55+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-announces-initiation-of-phase-2-3-mahogany-study-of-margetuximab-in-gastric-or-gastroesophageal-junction-cancer/attachment/macscience-1336663_960_720/ 2019-10-28T11:04:01+00:00 https://www.pharmaceutical-business-review.com/suppliers/actide/attachment/actide-logo/ 2019-10-28T13:46:44+00:00 https://www.pharmaceutical-business-review.com/contractors/actide/news/actide-showcase-cphi-2019/attachment/cphi/ 2019-10-28T13:52:21+00:00 https://www.pharmaceutical-business-review.com/suppliers/actide/attachment/1-ecrf/ 2019-10-28T13:54:14+00:00 https://www.pharmaceutical-business-review.com/suppliers/actide/attachment/2-database/ 2019-10-28T13:54:24+00:00 https://www.pharmaceutical-business-review.com/suppliers/actide/attachment/3-software/ 2019-10-28T13:54:33+00:00 https://www.pharmaceutical-business-review.com/contractors/actide/news/phuse-eu-connect-2019/attachment/phuse2/ 2019-10-28T13:59:06+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-bavencio-axitinib/attachment/pfizer-2-2/ 2019-10-29T08:15:02+00:00 https://www.pharmaceutical-business-review.com/news/gilead-and-glympse-bio-announce-strategic-collaboration-for-use-of-biomarker-technology-in-nash-clinical-development/attachment/hepatitis/ 2019-10-29T09:31:18+00:00 https://www.pharmaceutical-business-review.com/news/gsk-phase-3-program-gepotidacin/attachment/gsk-house-location-building/ 2019-10-29T10:00:43+00:00 https://www.pharmaceutical-business-review.com/news/terns-fxr-agonist-nash/attachment/fdadrug-49/ 2019-10-30T07:39:48+00:00 https://www.pharmaceutical-business-review.com/news/femtogenix-presents-data-on-antibody-drug-conjugates-containing-reduced-potency-payloads-in-solid-tumour-models/attachment/virus-10/ 2019-10-30T09:17:10+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-inflammasome/attachment/800px-siedziba_boehringer_ingelheim_w_polsce-4/ 2019-10-30T10:38:10+00:00 https://www.pharmaceutical-business-review.com/news/themis-mv-lasv-lassa-fever-vaccine/attachment/syringe-417786_960_720/ 2019-10-30T11:11:38+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-europe-russia-cheplapharm/attachment/russia/ 2019-10-31T07:36:15+00:00 https://www.pharmaceutical-business-review.com/news/roches-marketing-applications-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-accepted-for-review-by-ema-and-fda/attachment/roche-8/ 2019-10-31T09:30:46+00:00 https://www.pharmaceutical-business-review.com/news/acadia-pharmaceuticals-initiates-phase-3-pivotal-study-of-trofinetide-in-rett-syndrome/attachment/acscience-1336663_960_720/ 2019-10-31T10:08:14+00:00 https://www.pharmaceutical-business-review.com/news/pandion-astellas-pancreas-immunomodulators/attachment/plab-3498584_960_720/ 2019-10-31T10:34:13+00:00 https://www.pharmaceutical-business-review.com/news/roche-dicerna-hbv-infection/attachment/basel/ 2019-11-01T07:42:02+00:00 https://www.pharmaceutical-business-review.com/news/cycle-pharmaceuticals-and-catalent-partner-to-develop-treatments-for-rare-diseases-using-zydis-odt-technology/attachment/zydis/ 2019-11-01T09:32:56+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-initiates-clinical-trial-of-ds-7300-in-collaboration-with-sarah-cannon-research-institute/attachment/dtest-214185_960_720/ 2019-11-01T10:57:43+00:00 https://www.pharmaceutical-business-review.com/contractors/alpex-pharma-pbr-storefront/news/alpex-pharma-cphi-worldwide/attachment/alpex-pr/ 2019-11-01T14:28:49+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-exceed-trial/attachment/novartis-tower-with-logo-image-2/ 2019-11-04T07:12:42+00:00 https://www.pharmaceutical-business-review.com/news/amgen-celgene-psoriasis-otezla/attachment/amgenhead-5/ 2019-11-04T10:18:13+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-begins-phase-1-trial-with-bcx9250-for-treatment-of-fibrodysplasia-ossificans-progressiva/attachment/blab-3498584_960_720/ 2019-11-04T10:27:04+00:00 https://www.pharmaceutical-business-review.com/contractors/%supplier_name%/news/ftir-lumos-ii/attachment/lumos-ii_ftir-microscope_bruker_optics/ 2019-11-04T12:19:39+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/outsourcing-project/attachment/nsf-ph-white-paper-is-your-outsourcing-project-out-of-mind-and-out-of-hand/ 2019-11-04T14:50:04+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-pegph20-halo-301-trial/attachment/hlaboratory-3827745_960_720/ 2019-11-05T06:52:28+00:00 https://www.pharmaceutical-business-review.com/news/samsung-biologics-and-ichnos-sciences-announce-agreement-for-manufacture-of-isb-830/attachment/samsung-biologics/ 2019-11-05T11:05:27+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-fluzone-vaccine-quadrivalent/attachment/csr-2014/ 2019-11-05T12:09:27+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/protac-synthesis/attachment/wp_25-11/ 2019-11-05T14:32:13+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/protac-synthesis/attachment/wp_05-11/ 2019-11-05T14:32:19+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/protac-synthesis/attachment/wp_11-11/ 2019-11-05T14:32:23+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/protac-synthesis/attachment/wp_18-11/ 2019-11-05T14:32:26+00:00 https://www.pharmaceutical-business-review.com/news/redhill-talicia-h-pylori-infection/attachment/800px-fda_bldg_51_-_main_entrance_5161374834-2/ 2019-11-06T03:56:27+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-pegfilgrastim-biosimilar-ziextenzo/attachment/tower-with-logo-through-branches-image1-2/ 2019-11-06T06:36:36+00:00 https://www.pharmaceutical-business-review.com/news/japans-takeda-opens-dengue-vaccine-manufacturing-facility-in-germany/attachment/singen/ 2019-11-06T08:00:42+00:00 https://www.pharmaceutical-business-review.com/news/a2-biotherapeutics-emerges-from-stealth-mode-to-develop-tumour-cell-therapeutics/attachment/therapy-2/ 2019-11-06T09:04:52+00:00 https://www.pharmaceutical-business-review.com/news/cyclica-collaborates-with-enamine-to-use-real-technology-in-its-ligand-design-platform-for-ai-augmented-drug-design/attachment/cyartificial-intelligence-3382507_960_720/ 2019-11-06T10:38:31+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-vyriad-oncolytic-virus/attachment/regeneron/ 2019-11-07T08:56:10+00:00 https://www.pharmaceutical-business-review.com/news/axcella-achieves-initial-milestones-with-its-hematology-product-candidate-axa4010/attachment/bloodhemo/ 2019-11-07T09:51:57+00:00 https://www.pharmaceutical-business-review.com/news/samsung-bioepis-enters-into-commercialisation-agreement-for-next-generation-biosimilar-candidates/attachment/sabusiness-3152586_960_720/ 2019-11-07T10:57:37+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/logo-9/ 2019-11-07T14:09:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/regmed-image-1/ 2019-11-07T14:10:54+00:00 https://www.pharmaceutical-business-review.com/news/takedas-dengue-vaccine-candidate-demonstrates-protection-in-children-ages-four-to-16-years/attachment/takeda-4/ 2019-11-08T09:10:38+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-ebola-vaccine/attachment/jandj-3/ 2019-11-08T09:14:57+00:00 https://www.pharmaceutical-business-review.com/news/fda-reblozyl-anaemia-beta-thalassemia/attachment/blood-1813410_1280/ 2019-11-11T07:05:25+00:00 https://www.pharmaceutical-business-review.com/news/stone-capital-partners-biosyngen-to-setup-50m-biopharmaceutical-investment-fund-in-singapore/attachment/biosyngen-stone-capital-signing/ 2019-11-11T11:20:30+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/data-integrity-elearning/attachment/rachel-carmichael/ 2019-11-11T13:48:23+00:00 https://www.pharmaceutical-business-review.com/news/novartis-sandoz-aspen/attachment/novartis-3/ 2019-11-12T07:56:53+00:00 https://www.pharmaceutical-business-review.com/news/atai-life-sciences-and-cyclica-launch-joint-venture-to-revolutionise-drug-development-for-mental-health-disorders/attachment/mental/ 2019-11-12T08:59:15+00:00 https://www.pharmaceutical-business-review.com/news/nec-and-vaximm-announce-collaboration-to-advance-personalized-neoantigen-cancer-vaccines/attachment/laboratory-3827745_640/ 2019-11-12T11:47:12+00:00 https://www.pharmaceutical-business-review.com/news/roches-risdiplam-sunfish-trial/attachment/roche-location-6/ 2019-11-12T12:17:34+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-jardiance/attachment/lilli-2/ 2019-11-13T06:43:12+00:00 https://www.pharmaceutical-business-review.com/news/lupin-sell-kyowa-unison/attachment/vinita-gupta/ 2019-11-13T11:19:07+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pfizer-announce-viatris-as-new-company-name/attachment/pfizerworldheadquartersentrance-8/ 2019-11-13T11:24:53+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/robyn-meurant-bivda/attachment/robyn-meurant/ 2019-11-13T14:10:14+00:00 https://www.pharmaceutical-business-review.com/news/merck-calporta-therapeutics/attachment/merck/ 2019-11-14T07:42:29+00:00 https://www.pharmaceutical-business-review.com/news/rdd-pharma-signs-loi-to-acquire-naia-rare-diseases/attachment/rdi/ 2019-11-14T09:44:12+00:00 https://www.pharmaceutical-business-review.com/news/gsks-mepolizumab-phase-3-trial/attachment/glaxo_smith_kline_offices_on_the_great_west_road_at_brentford_-_panoramio/ 2019-11-14T09:59:02+00:00 https://www.pharmaceutical-business-review.com/news/finch-therapeutics-takeda-expand-collaboration-to-develop-microbiome-therapeutics/attachment/agreement-3489902_6401/ 2019-11-14T10:16:22+00:00 https://www.pharmaceutical-business-review.com/news/shionogi-cuti-drug-fetroja/attachment/fdadrug-51/ 2019-11-15T07:46:46+00:00 https://www.pharmaceutical-business-review.com/news/epicentrx-closes-35m-series-d-financing-to-support-development-of-small-molecule-immunotherapy-and-oncolytic-viral-platform/attachment/virus-11/ 2019-11-15T09:29:53+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-regulatory-submission-for-selumetinib/attachment/medimmune-gaithersburg-us/ 2019-11-15T10:52:39+00:00 https://www.pharmaceutical-business-review.com/news/roche-promedior-biotechnology/attachment/basel-2/ 2019-11-18T06:50:09+00:00 https://www.pharmaceutical-business-review.com/news/qtrilmet-approved-in-eu-to-treat-type-2-diabetes/attachment/medicinetab/ 2019-11-18T09:18:34+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-company-announces-that-the-orion-10-study-of-inclisiran-showed-durable-and-potent-lowering-of-ldl-c/attachment/test-214185_640-2/ 2019-11-18T10:27:19+00:00 https://www.pharmaceutical-business-review.com/products/ft-ir-and-raman-microscopes-pharmaceutical/attachment/lumos-ii_ftir-microscope_bruker_optics-2/ 2019-11-18T14:02:23+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-rodin-therapeutics/attachment/rodin/ 2019-11-19T07:38:34+00:00 https://www.pharmaceutical-business-review.com/news/aerie-pharmaceuticals-agrees-to-acquire-avizorex-pharma/attachment/pharma-3/ 2019-11-19T09:29:15+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-novo-nordisk-rnai-deal/attachment/novo-nordisk-headquarters-2/ 2019-11-19T11:54:35+00:00 https://www.pharmaceutical-business-review.com/news/cns-pharmaceuticals-acquired-worldwide-rights-for-brain-cancer-drug-from-houston-pharmaceuticals/attachment/drug-12/ 2019-11-20T08:27:19+00:00 https://www.pharmaceutical-business-review.com/news/newron-sarizotan-rett-syndrome/attachment/fda_bldg_51_-_main_entrance_5161374834-7/ 2019-11-20T10:08:00+00:00 https://www.pharmaceutical-business-review.com/news/sangamo-announces-uk-authorisation-of-a-phase-1-2-clinical-trial-evaluating-the-car-treg-cell-therapy-tx200-for-kidney-transplantation/attachment/test-214185_6401/ 2019-11-20T10:14:13+00:00 https://www.pharmaceutical-business-review.com/contractors/vetter_pharma_international/news/greater-flexibility-secondary-packaging/attachment/vetter-provides-greater-flexibility-in-secondary-packaging-through-colla-_/ 2019-11-20T10:53:50+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-celgene/attachment/pomalyst-2/ 2019-11-21T07:35:02+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-announces-approval-of-givlaari-by-us-fda/attachment/gilvari/ 2019-11-21T08:59:28+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-nih-collaborate-on-investigational-bnab-for-hiv-treatment/attachment/gsk-house-location-building-2/ 2019-11-22T10:30:35+00:00 https://www.pharmaceutical-business-review.com/news/vor-biopharma-and-maxcyte-announce-clinical-and-commercial-licence-agreement-for-engineered-hematopoietic-stem-cells-to-treat-cancer/attachment/cancer-4/ 2019-11-22T11:25:05+00:00 https://www.pharmaceutical-business-review.com/suppliers/faubel-pharma-business-review/attachment/faubel-pharma-services_products/ 2019-11-22T11:33:29+00:00 https://www.pharmaceutical-business-review.com/news/deals/novartis-medicines-company-deal/attachment/novartis-tower-with-logo-image-4/ 2019-11-25T06:27:20+00:00 https://www.pharmaceutical-business-review.com/news/novartis-adakveo-fda-sickle-cell/attachment/novartis-tower-with-logo-image-3/ 2019-11-25T06:28:33+00:00 https://www.pharmaceutical-business-review.com/news/soliris-receives-approval-in-japan-for-the-prevention-of-relapse-in-patients-with-neuromyelitis-optica-spectrum-disorder/attachment/laboratory-3827745_6401/ 2019-11-25T11:22:34+00:00 https://www.pharmaceutical-business-review.com/news/alexion-receives-fda-approval-for-ultomiris-for-atypical-hemolytic-uremic-syndrome/attachment/fdadrug-46/ 2019-11-25T11:26:01+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/improve-material-release-process/attachment/bravo_brochure_pharma_bruker_optics/ 2019-11-25T12:01:37+00:00 https://www.pharmaceutical-business-review.com/news/roche-tecentriq-avastin-imbrave150/attachment/roche-location-7/ 2019-11-25T12:25:12+00:00 https://www.pharmaceutical-business-review.com/suppliers/lfa-machines/attachment/fully-automatic-capsule-filler/ 2019-11-25T16:26:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/lfa-machines/attachment/rotary-tablet-press-rtp-41/ 2019-11-25T16:27:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/lfa-machines/attachment/vh-200-powder-mixer/ 2019-11-25T16:27:19+00:00 https://www.pharmaceutical-business-review.com/suppliers/lfa-machines/attachment/desktop-tablet-press-tdp5/ 2019-11-25T16:27:25+00:00 https://www.pharmaceutical-business-review.com/suppliers/lfa-machines/attachment/lfa-logo/ 2019-11-25T16:31:29+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-infliximab-remsima-sc/attachment/rheumatoid/ 2019-11-26T07:48:24+00:00 https://www.pharmaceutical-business-review.com/news/epicentrx-announces-positive-results-from-phase-1-trial-of-rrx-001-as-first-line-treatment-in-newly-diagnosed-glioblastoma/attachment/test-214185_6402/ 2019-11-26T09:34:45+00:00 https://www.pharmaceutical-business-review.com/news/ferring-blackstone-gene-therapy/attachment/dna-3539309_640/ 2019-11-26T10:09:17+00:00 https://www.pharmaceutical-business-review.com/news/carb-x-funds-venatorx-to-support-development-of-new-class-of-oral-antibiotics-to-treat-multi-drug-resistant-gonorrhoea/attachment/pill-3/ 2019-11-26T10:25:58+00:00 https://www.pharmaceutical-business-review.com/suppliers/lfa-machines/attachment/rtp-tooling-700x700/ 2019-11-26T10:39:54+00:00 https://www.pharmaceutical-business-review.com/products/rotary-tablet-press/attachment/rotary-tablet-press-rtp33/ 2019-11-26T11:04:36+00:00 https://www.pharmaceutical-business-review.com/products/rotary-tablet-press/attachment/hstp-high-speed-tablet-press-main/ 2019-11-26T12:16:08+00:00 https://www.pharmaceutical-business-review.com/products/rotary-tablet-press/attachment/rtp-10i-rotart-tablet-press-main/ 2019-11-26T12:16:20+00:00 https://www.pharmaceutical-business-review.com/products/rotary-tablet-press/attachment/rotary-tablet-press-rtp-41-2/ 2019-11-26T12:16:32+00:00 https://www.pharmaceutical-business-review.com/products/desktop-tablet-presses/attachment/dtp12-main/ 2019-11-26T12:25:39+00:00 https://www.pharmaceutical-business-review.com/products/desktop-tablet-presses/attachment/desktop-tablet-press-tdp0/ 2019-11-26T12:25:57+00:00 https://www.pharmaceutical-business-review.com/products/desktop-tablet-presses/attachment/tdp-1-5-main/ 2019-11-26T12:26:08+00:00 https://www.pharmaceutical-business-review.com/products/desktop-tablet-presses/attachment/desktop-tablet-press-tdp5-2/ 2019-11-26T12:26:20+00:00 https://www.pharmaceutical-business-review.com/products/desktop-tablet-presses/attachment/tdp-6s-tablet-press-main/ 2019-11-26T12:26:26+00:00 https://www.pharmaceutical-business-review.com/products/tablet-dedusters/attachment/tdd1-close-de-duster/ 2019-11-26T12:33:40+00:00 https://www.pharmaceutical-business-review.com/products/tablet-dedusters/attachment/uhdd-200-tablet-de-duster/ 2019-11-26T12:34:11+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/rbm-ribbon-blender-mixer/ 2019-11-26T12:37:57+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/ribbon-blender-mixer/ 2019-11-26T12:38:06+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/lsm-mixer/ 2019-11-26T12:38:15+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/ctm-powder-mixer/ 2019-11-26T12:38:20+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/fbm-powder-mixer/ 2019-11-26T12:38:30+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/gfd-photos/ 2019-11-26T12:38:35+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/blm-mixer/ 2019-11-26T12:38:44+00:00 https://www.pharmaceutical-business-review.com/products/mixers/attachment/vh-200-powder-mixer-2/ 2019-11-26T12:41:09+00:00 https://www.pharmaceutical-business-review.com/products/tablet-dedusters/attachment/tabvac-tablet-dust-vacuum/ 2019-11-26T12:42:47+00:00 https://www.pharmaceutical-business-review.com/products/manual-capsule-fillers/attachment/procap-manual-capsule-filler/ 2019-11-26T12:50:25+00:00 https://www.pharmaceutical-business-review.com/products/semi-automatic-and-fully-automatic-capsule-filling-machines/attachment/sacf-25-side-facing/ 2019-11-26T12:53:34+00:00 https://www.pharmaceutical-business-review.com/products/semi-automatic-and-fully-automatic-capsule-filling-machines/attachment/fully-automatic-capsule-filler-2/ 2019-11-26T12:53:44+00:00 https://www.pharmaceutical-business-review.com/products/vice-manual-tablet-press/attachment/silver-hero-on-white/ 2019-11-26T12:55:41+00:00 https://www.pharmaceutical-business-review.com/products/gr-powder-granulator/attachment/gr-granulators-main/ 2019-11-26T13:03:19+00:00 https://www.pharmaceutical-business-review.com/products/capsule-polisher/attachment/cp-7000-capsule-polisher/ 2019-11-26T13:05:04+00:00 https://www.pharmaceutical-business-review.com/products/mixer-cleaning-machines/attachment/mixer-cleaning-machines/ 2019-11-26T13:06:52+00:00 https://www.pharmaceutical-business-review.com/products/tablet-dedusters/attachment/tdd1-de-duster/ 2019-11-26T15:29:55+00:00 https://www.pharmaceutical-business-review.com/products/mixer-cleaning-machines/attachment/mixer-cleaning/ 2019-11-26T15:37:49+00:00 https://www.pharmaceutical-business-review.com/news/asahi-kasei-veloxis-pharmaceuticals/attachment/asahi_kasei_nobeoka_branch_2010/ 2019-11-27T06:06:34+00:00 https://www.pharmaceutical-business-review.com/news/lonza-and-dinaqor-announce-strategic-collaboration-to-advance-gene-therapy-programs-for-patients-with-monogenic-cardiomyopathies/attachment/dna-1903318_640/ 2019-11-27T10:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-dysport-spasticity-children/attachment/fdadrug-44/ 2019-11-28T11:02:00+00:00 https://www.pharmaceutical-business-review.com/news/verrica-pharmaceuticals-announces-fda-filing-acceptance-of-nda-for-vp-102-to-treat-molluscum-contagiosum/attachment/fdadrug-53/ 2019-11-28T13:03:18+00:00 https://www.pharmaceutical-business-review.com/news/novartis-cell-gene-therapies/attachment/novartisfacility/ 2019-11-29T07:51:31+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-atu-and-genemedicine-sign-development-and-manufacturing-agreement-for-oncolytic-virus-products/attachment/virusparticle-2/ 2019-11-29T09:18:09+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-imfinzi-extensive-stage-sclc/attachment/cq5dam-web-1200-az1572_equipment-2/ 2019-11-29T10:59:22+00:00 https://www.pharmaceutical-business-review.com/news/medincell-receives-19m-grant-for-mdc-wwm-programme/attachment/1280px-bill_and_melinda_gates_foundation_front/ 2019-11-29T11:05:16+00:00 https://www.pharmaceutical-business-review.com/products/zetasizer-pro/attachment/zetasizer-pro/ 2019-11-29T14:09:08+00:00 https://www.pharmaceutical-business-review.com/products/zetasizer-nano/attachment/zetasizer-nano/ 2019-11-29T14:12:53+00:00 https://www.pharmaceutical-business-review.com/products/zetasizer-ultra/attachment/zetasizer-ultra/ 2019-11-29T14:14:44+00:00 https://www.pharmaceutical-business-review.com/products/zetasizer-at/attachment/zetasizer-at/ 2019-11-29T14:23:04+00:00 https://www.pharmaceutical-business-review.com/products/zetium-malvern/attachment/zetium-2/ 2019-11-29T14:25:56+00:00 https://www.pharmaceutical-business-review.com/products/empyrean-malvern/attachment/empyrean-nan/ 2019-11-29T14:30:35+00:00 https://www.pharmaceutical-business-review.com/products/empyrean-malvern/attachment/alpha-1/ 2019-11-29T14:30:41+00:00 https://www.pharmaceutical-business-review.com/products/nanosight/attachment/nanosight-lm10/ 2019-11-29T14:36:47+00:00 https://www.pharmaceutical-business-review.com/products/epsilon-1/attachment/epsilon-1-2/ 2019-11-29T14:43:51+00:00 https://www.pharmaceutical-business-review.com/products/morphologi-malvern/attachment/morph-4/ 2019-11-29T14:46:10+00:00 https://www.pharmaceutical-business-review.com/products/morphologi-malvern/attachment/morph-4id/ 2019-11-29T14:47:25+00:00 https://www.pharmaceutical-business-review.com/products/epsilon-xflow/attachment/epsilon-xl/ 2019-11-29T14:49:50+00:00 https://www.pharmaceutical-business-review.com/news/sensorions-seliforant-primary-endpoint/attachment/ear/ 2019-12-02T08:53:33+00:00 https://www.pharmaceutical-business-review.com/news/lunac-therapeutics-led-project-awarded-3-14m-under-innovate-uk-biomedical-catalyst-programme-to-develop-next-generation-anticoagulant/attachment/test-214185_6403/ 2019-12-02T10:54:55+00:00 https://www.pharmaceutical-business-review.com/news/astellas-audentes-therapeutics/attachment/audent/ 2019-12-03T07:12:35+00:00 https://www.pharmaceutical-business-review.com/news/phathom-pharmaceuticals-announces-initiation-of-pivotal-phase-3-clinical-trial-for-vonoprazan-in-erosive-esophagitis/attachment/pharma-4/ 2019-12-03T09:05:07+00:00 https://www.pharmaceutical-business-review.com/news/knopp-biosciences-university-of-leicester-release-details-of-phase-2-trial-of-dexpramipexole-in-severe-eosinophilic-asthma/attachment/1920px-university_of_leicester_towers_2010/ 2019-12-03T09:46:57+00:00 https://www.pharmaceutical-business-review.com/news/stada-biopharma-ukraine-deal/attachment/stada_headquarter_building_bad_vilbel/ 2019-12-03T10:27:55+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/sf5-containing-building-blocks/attachment/wp_03-12/ 2019-12-03T10:35:16+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/sf5-containing-building-blocks/attachment/wp_09-12/ 2019-12-03T10:35:20+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/sf5-containing-building-blocks/attachment/wp_16-12/ 2019-12-03T10:35:23+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/sf5-containing-building-blocks/attachment/wp_23-12/ 2019-12-03T10:35:27+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/dextrose-monohydrate-packet/ 2019-12-03T13:28:56+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/dicalcium-phosphate-packet/ 2019-12-03T13:29:01+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/empty-gelatin-ps-v1/ 2019-12-03T13:29:05+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/empty-vegetable-capsules/ 2019-12-03T13:29:09+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/firmapress-pill-mix-main/ 2019-12-03T13:29:14+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/firmmafill/ 2019-12-03T13:29:18+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/gel-seperated/ 2019-12-03T13:29:21+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/hpmc-render-v1/ 2019-12-03T13:29:24+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/lactose-powder-packet/ 2019-12-03T13:29:29+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/magnesium-stearate-packet/ 2019-12-03T13:29:33+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/microcrystalline-cellulose-packet/ 2019-12-03T13:29:37+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/silicon-dioxide-packet/ 2019-12-03T13:29:42+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/veggie-capsules-seperated/ 2019-12-03T13:29:45+00:00 https://www.pharmaceutical-business-review.com/products/excipients/attachment/firmaoil/ 2019-12-03T13:30:01+00:00 https://www.pharmaceutical-business-review.com/news/roche-tecentriq-metastatic-nsclc/attachment/rochebuild-4/ 2019-12-04T07:52:26+00:00 https://www.pharmaceutical-business-review.com/news/iontas-and-adaptate-biotherapeutics-collaborate-to-identify-optimised-antibodies-for-novel-cancer-targets/attachment/bacteria-3/ 2019-12-04T09:41:07+00:00 https://www.pharmaceutical-business-review.com/news/fda-incyte-nda-pemigatinib/attachment/fdadrug-52/ 2019-12-04T10:21:02+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-orencia/attachment/bmsfacility-3/ 2019-12-05T07:22:54+00:00 https://www.pharmaceutical-business-review.com/news/aws-announces-strategic-collaboration-with-novartis-to-accelerate-digital-transformation-of-its-business-operations/attachment/novar-4/ 2019-12-05T10:05:36+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-fostemsavir-hiv-1/attachment/hivvirus/ 2019-12-06T07:46:08+00:00 https://www.pharmaceutical-business-review.com/news/fergenes-phase-3-nmibc-study-of-nadofaragene-firadenovec-meets-primary-endpoint/attachment/dna-163466_640/ 2019-12-06T09:39:00+00:00 https://www.pharmaceutical-business-review.com/contractors/tosoh-bioscience/news/protein-purification-and-analysis/attachment/masanobu-kasai/ 2019-12-06T09:59:44+00:00 https://www.pharmaceutical-business-review.com/news/limelight-bio-emerges-with-75m-to-develop-next-generation-gene-therapies-to-overcome-limitations-of-current-treatments/attachment/pill-4/ 2019-12-06T13:16:32+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbs-liso-cel/attachment/bmsfacility-4/ 2019-12-09T07:35:20+00:00 https://www.pharmaceutical-business-review.com/news/calquence-significantly-prolonged-time-patients-lived-without-disease-progression-or-death-in-previously-untreated-cll/attachment/tablet-8/ 2019-12-09T09:16:22+00:00 https://www.pharmaceutical-business-review.com/news/kites-yescarta-yields-positive-results-in-zuma-1-trial-in-refractory-large-b-cell-lymphoma/attachment/science-1336663_640/ 2019-12-09T10:56:53+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-bermekimab-janssen/attachment/job-4131482_6402/ 2019-12-09T11:28:36+00:00 https://www.pharmaceutical-business-review.com/news/merck-biopharmaceutical-arqule/attachment/orcule/ 2019-12-10T07:21:11+00:00 https://www.pharmaceutical-business-review.com/news/incheon-city-envisions-biotech-mecca-by-developing-songdo-global-biotech-cluster/attachment/ifez/ 2019-12-10T09:37:47+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-acquire-synthorx-deal/attachment/800px-sanofi_frankfurt_iph/ 2019-12-10T12:29:03+00:00 https://www.pharmaceutical-business-review.com/news/amneal-generic-avkar/attachment/amneal/ 2019-12-11T07:13:46+00:00 https://www.pharmaceutical-business-review.com/news/retrogenix-and-resonant-therapeutics-announce-strategic-alliance-to-identify-targets-of-anti-tumour-antibodies/attachment/virusparticle-3/ 2019-12-11T09:16:47+00:00 https://www.pharmaceutical-business-review.com/news/dermira-lebrikizumab-fda-fast-track/attachment/fda_bldg_51_-_main_entrance_5161374834-8/ 2019-12-11T09:53:49+00:00 https://www.pharmaceutical-business-review.com/news/vedanta-biosciences-initiates-first-in-patient-study-of-ve800-in-combination-with-bristol-myers-squibbs-opdivo/attachment/cancer-cells-541954_640/ 2019-12-11T10:23:46+00:00 https://www.pharmaceutical-business-review.com/news/leo-pharma-tralokinumab-dermatitis/attachment/atopy/ 2019-12-12T07:19:26+00:00 https://www.pharmaceutical-business-review.com/news/fully-human-bcma-car-t-clinical-results-to-treat-relapsed-refractory-multiple-myeloma-co-developed-by-iaso-bio-and-innovent-presented-at-the-2019-ash-annual-meeting/attachment/ash/ 2019-12-12T10:10:42+00:00 https://www.pharmaceutical-business-review.com/news/trastuzumab-deruxtecan-achieves-tumour-response-rate-of-60-9-in-pivotal-phase-ii-her2-positive-metastatic-breast-cancer-trial/attachment/astra-5/ 2019-12-12T10:16:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/documentation-complexity-at-crisis-point/attachment/nsf-ph-white-paper-documentation-complexity-at-crisis-point/ 2019-12-12T15:16:06+00:00 https://www.pharmaceutical-business-review.com/news/3m-drug-delivery-altaris-capital/attachment/thermometer-1539191_640/ 2019-12-13T09:46:57+00:00 https://www.pharmaceutical-business-review.com/news/meitheal-pharmaceuticals-announces-fda-approval-of-enoxaparin-sodium-injection-usp/attachment/fdadrug-54/ 2019-12-13T11:34:58+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/permasure-ph-eur-5-24-ft-ir-imaging/attachment/permasure/ 2019-12-13T11:37:34+00:00 https://www.pharmaceutical-business-review.com/news/novartis-fevipiprant-asthma-studies/attachment/novartis-tower/ 2019-12-16T07:54:17+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-votes-unanimously-to-support-use-of-teprotumumab-to-treat-thyroid-eye-disease/attachment/fdadrug-55/ 2019-12-16T10:27:56+00:00 https://www.pharmaceutical-business-review.com/news/genentech-announces-results-of-imspire150-study-in-braf-v600-mutation-positive-advanced-melanoma/attachment/genetech-0081967-2/ 2019-12-16T11:18:54+00:00 https://www.pharmaceutical-business-review.com/news/jardiance-phase-3-exercise-ability-studies/attachment/1024px-eli_lilly_corporate_center_indianapolis_indiana_usa-2/ 2019-12-16T12:02:33+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-laboratories-hemacare/attachment/hemacare/ 2019-12-17T07:26:13+00:00 https://www.pharmaceutical-business-review.com/news/organovo-and-tarveda-therapeutics-announce-definitive-merger-agreement/attachment/organo/ 2019-12-17T09:35:43+00:00 https://www.pharmaceutical-business-review.com/news/xtandi-prostate-cancer-fda/attachment/pfizerworldheadquartersentrance-9/ 2019-12-17T12:22:38+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-dicerna-deficiency/attachment/liverorgan/ 2019-12-18T07:35:52+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pear-therapeutics-announces-first-patient-dosed-in-part-ii-of-pear-006-feasibility-study/attachment/kidney-4/ 2019-12-18T09:36:28+00:00 https://www.pharmaceutical-business-review.com/news/amylyx-pharmaceuticals-announces-amx0035-demonstrated-statistically-significant-treatment-benefit-in-als-in-centaur-trial/attachment/lab-3498584_640/ 2019-12-18T10:49:48+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-and-grants-priority-review-to-snda-for-braftovi-in-combination-with-erbitux-to-treat-brafv600e-mutant-metastatic-colorectal-cancer-after-prior-therapy/attachment/pfizer-13/ 2019-12-19T10:16:54+00:00 https://www.pharmaceutical-business-review.com/news/astellas-seattle-genetics-get-fdas-accelerated-approval-for-bladder-cancer-drug-padcev/attachment/padcev/ 2019-12-19T10:44:59+00:00 https://www.pharmaceutical-business-review.com/news/arcus-collaborates-with-genentech-for-two-randomised-clinical-studies-of-ab928/attachment/cancer-cells-541954_6401/ 2019-12-19T10:46:12+00:00 https://www.pharmaceutical-business-review.com/news/roche-kadcyla-breast-cancer/attachment/basel-1/ 2019-12-20T07:19:36+00:00 https://www.pharmaceutical-business-review.com/news/achillion-shareholders-approve-agreement-to-be-acquired-by-alexion/attachment/achillion/ 2019-12-20T09:27:08+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-enters-into-a-clinical-collaboration-for-three-phase-3-combination-trials-in-advanced-solid-tumours/attachment/test-214185_6404/ 2019-12-20T11:14:03+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-pancreatic-lynparza/attachment/astratablet-4/ 2019-12-30T10:11:05+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-fulcrum-pulmonary-research/attachment/acceleron/ 2019-12-31T07:12:13+00:00 https://www.pharmaceutical-business-review.com/news/gsk-vaccine-brands-bavarian-nordic/attachment/gsk-house-location-building-3/ 2020-01-02T06:28:27+00:00 https://www.pharmaceutical-business-review.com/news/amgen-beigene-oncology-china/attachment/hires-illumina-building-entrance/ 2020-01-03T10:44:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/para-substituted-benzenes/attachment/06-01/ 2020-01-03T14:37:09+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/para-substituted-benzenes/attachment/20-01/ 2020-01-03T14:37:12+00:00 https://www.pharmaceutical-business-review.com/suppliers/denny-bros/attachment/dblogo/ 2020-01-03T15:44:47+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-dysport-cerebral-palsy/attachment/ipsen/ 2020-01-06T08:23:55+00:00 https://www.pharmaceutical-business-review.com/news/leap-therapeutics-and-beigene-announce-exclusive-option-and-license-agreement-for-dkn-01/attachment/job-4131482_6404/ 2020-01-06T12:06:21+00:00 https://www.pharmaceutical-business-review.com/news/deals/charles-river-laboratories-hemacare-2/attachment/handshake-3655926_6403/ 2020-01-06T13:21:10+00:00 https://www.pharmaceutical-business-review.com/news/merck-enters-into-2-5bn-oncology-deal-with-taiho-and-astex/attachment/drug-target/ 2020-01-07T09:20:39+00:00 https://www.pharmaceutical-business-review.com/news/merck-enters-into-2-5bn-oncology-deal-with-taiho-and-astex/attachment/drug-target-2/ 2020-01-07T09:22:23+00:00 https://www.pharmaceutical-business-review.com/news/veristat-strengthens-its-european-presence-with-acquisition-of-the-clinical-trial-company/attachment/trial-5/ 2020-01-07T09:55:53+00:00 https://www.pharmaceutical-business-review.com/news/glycomimetics-apollomics-announce-collaboration-and-license-agreement-for-gmi-1687/attachment/deal-4131445_6401/ 2020-01-07T11:24:42+00:00 https://www.pharmaceutical-business-review.com/news/farxiga-fda-priority-review-heart-failure/attachment/astrazeneca-hq-12/ 2020-01-07T12:51:47+00:00 https://www.pharmaceutical-business-review.com/news/bicycle-therapeutics-cancer-research/attachment/bicycle/ 2020-01-08T07:56:52+00:00 https://www.pharmaceutical-business-review.com/news/incyte-announces-validation-by-ema-of-its-maa-for-pemigatinib-in-patients-with-cholangiocarcinoma/attachment/carcinoma/ 2020-01-08T10:43:47+00:00 https://www.pharmaceutical-business-review.com/news/sab-biotherapeutics-announces-research-collaboration-with-csl-behring/attachment/business-4107640_640/ 2020-01-08T10:58:34+00:00 https://www.pharmaceutical-business-review.com/news/tyme-eagle-sm-88-advanced-cancers/attachment/cancer-cells-541954_6402/ 2020-01-08T13:20:50+00:00 https://www.pharmaceutical-business-review.com/news/merck-keytruda-nmibc/attachment/keytruda-4/ 2020-01-09T06:39:10+00:00 https://www.pharmaceutical-business-review.com/news/schrodinger-bayer-collaborate-to-co-develop-de-novo-design-technology-to-accelerate-drug-discovery/attachment/tablet-9/ 2020-01-09T08:44:17+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-duchenne-uk-announce-partnership-to-evaluate-edasalonexent-in-phase-2-non-ambulatory-dmd-trial/attachment/laboratory-3827745_6402/ 2020-01-09T11:14:23+00:00 https://www.pharmaceutical-business-review.com/news/empirico-ionis-antisense-therapeutics/attachment/drug-pill/ 2020-01-10T07:46:49+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gho-capital-acquires-cdmo-ardena/attachment/cdmo-2/ 2020-01-10T10:00:03+00:00 https://www.pharmaceutical-business-review.com/news/vbi-vaccines-announces-second-pivotal-phase-3-study-of-sci-b-vac-meets-primary-and-secondary-endpoints/attachment/syringe-1884758_640/ 2020-01-10T11:29:11+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-licences-portfolio-of-hiv-antibodies-from-the-rockefeller-university/attachment/hiv-3/ 2020-01-10T14:26:26+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-dermira/attachment/eli-lilly-2/ 2020-01-13T07:43:35+00:00 https://www.pharmaceutical-business-review.com/news/neurobo-pharmaceuticals-and-gemphire-therapeutics-complete-merger/attachment/merger-2/ 2020-01-13T09:45:27+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-fostemsavir-ema/attachment/hiv-1903373_640/ 2020-01-13T12:39:47+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/remediation-projects-industry/attachment/nsf-ph-white-paper-what-our-remediation-projects-are-saying-about-the-industry/ 2020-01-13T14:37:48+00:00 https://www.pharmaceutical-business-review.com/news/bayer-contraceptive-ovaprene/attachment/bayer-2/ 2020-01-14T07:14:39+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-takeda-announce-scientific-collaboration-to-identify-and-develop-preclinical-candidates/attachment/takedbuild/ 2020-01-14T09:47:58+00:00 https://www.pharmaceutical-business-review.com/news/biomotiv-and-atomwise-sign-ai-partnership-to-transform-therapeutic-development/attachment/artificial-intelligence-3382507_6403/ 2020-01-14T11:20:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/wek-tec/attachment/sbs-uv-c-tunnel-au-front3-col-adj/ 2020-01-14T11:31:11+00:00 https://www.pharmaceutical-business-review.com/suppliers/wek-tec/attachment/vortex-renewed1/ 2020-01-14T11:31:19+00:00 https://www.pharmaceutical-business-review.com/suppliers/wek-tec/attachment/pef-gw-6r2/ 2020-01-14T11:31:26+00:00 https://www.pharmaceutical-business-review.com/suppliers/wek-tec/attachment/puv-reprate-front-v3a/ 2020-01-14T11:31:50+00:00 https://www.pharmaceutical-business-review.com/suppliers/wek-tec/attachment/wt-logo-v2-20x20/ 2020-01-14T11:33:45+00:00 https://www.pharmaceutical-business-review.com/news/deals/astellas-adaptimmune-t-cell-therapy/attachment/dna-1903318_6401/ 2020-01-14T12:56:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/world-vaccine-congress/attachment/vaccine-conference/ 2020-01-15T13:16:03+00:00 https://www.pharmaceutical-business-review.com/suppliers/world-vaccine-congress/attachment/world-vaccine/ 2020-01-15T13:23:54+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-dovato/attachment/hivinfection-2/ 2020-01-16T06:06:04+00:00 https://www.pharmaceutical-business-review.com/news/twist-bioscience-announces-strategic-collaboration-with-schrodinger-for-drug-discovery/attachment/scrodinger/ 2020-01-16T10:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-priority-review-bristol-myers-squibbs-application-for-opdivo-plus-yervoy-in-first-line-nsclc/attachment/800px-bristol_myers_squibb_moreton_wirral_-_img_0369/ 2020-01-16T11:14:21+00:00 https://www.pharmaceutical-business-review.com/suppliers/wek-tec/attachment/wt-logo-v2-20x20-2/ 2020-01-16T16:51:24+00:00 https://www.pharmaceutical-business-review.com/news/merck-biopharmaceutical-firm-arqule/attachment/arcule/ 2020-01-17T07:31:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/wek-tec/attachment/wt-logo-v2-20x20-3/ 2020-01-17T09:03:05+00:00 https://www.pharmaceutical-business-review.com/news/neuroptika-announces-enrolment-of-first-patient-in-phase-2-clinical-trial-for-dry-eye-disease/attachment/dry-eye-3/ 2020-01-17T09:46:16+00:00 https://www.pharmaceutical-business-review.com/products/tlx-2-cargo-covers/attachment/insulation-on-pallet_2_cobranded_small_flat2/ 2020-01-17T10:22:20+00:00 https://www.pharmaceutical-business-review.com/products/tlx-2-cargo-covers/attachment/tlx2-after-reycling/ 2020-01-17T10:22:29+00:00 https://www.pharmaceutical-business-review.com/news/civica-rx-partners-with-thermo-fisher-scientific-to-develop-and-manufacture-drugs-with-a-history-of-drug-shortages/attachment/800px-thermofisherscientific2/ 2020-01-17T11:12:42+00:00 https://www.pharmaceutical-business-review.com/news/clarivate-analytics-decision-resources/attachment/piramal/ 2020-01-20T07:52:25+00:00 https://www.pharmaceutical-business-review.com/news/innovation-pharmaceuticals-announces-dose-escalation/attachment/tablet-10/ 2020-01-20T09:35:08+00:00 https://www.pharmaceutical-business-review.com/news/verrica-pharmaceuticals-announces-presentation-of-positive-data-from-new-pooled-analysis-of-phase-3-camp-trials-of-vp-102/attachment/test-214185_6405/ 2020-01-20T11:16:01+00:00 https://www.pharmaceutical-business-review.com/news/janssen-imbruvica-rituximab-ema/attachment/imbruvicaproductsh_1540765104569-hr/ 2020-01-20T12:06:41+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-tremelimumab-carcinoma/attachment/astra-6/ 2020-01-21T07:45:20+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-osa/attachment/jazztablet/ 2020-01-21T09:07:03+00:00 https://www.pharmaceutical-business-review.com/news/armas-pharmaceuticals-adds-four-generic-injectables-as-first-launches-of-2020/attachment/syringe-1884758_6401/ 2020-01-21T09:48:27+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/nitrosamine-risk-assessments/attachment/nitrosamine-social-image/ 2020-01-21T10:05:53+00:00 https://www.pharmaceutical-business-review.com/products/intense-pulsed-light-system/attachment/wt-pl-rd-reprate-system/ 2020-01-21T11:09:25+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/intense-pulsed-light/attachment/intense-pulsed-light-2/ 2020-01-21T16:40:24+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/hv-pulsed-electrical-fields/attachment/hv-pulsed-electrical-fields-2/ 2020-01-21T16:41:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/nutrition-powder-uv-sanitation/attachment/nutrition-powder-uv-sanitation-2/ 2020-01-21T16:42:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/%supplier_name%/whitepapers/bio-medical-staffs/attachment/modifications-of-bio-medical-staffs-with-high-magnetic-fields/ 2020-01-21T16:43:07+00:00 https://www.pharmaceutical-business-review.com/news/novel-coronavirus-us-patient/attachment/original-title-bldg21_0023-jpg-2/ 2020-01-22T06:13:54+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-pharmaceutical-north-carolina/attachment/eli-lilly-3/ 2020-01-22T07:17:39+00:00 https://www.pharmaceutical-business-review.com/news/calidi-biotherapeutics-secures-series-a-investments-to-advance-manufacturing/attachment/calidi_biotherapeutics/ 2020-01-22T10:39:27+00:00 https://www.pharmaceutical-business-review.com/products/technologies/attachment/pulse-light-destroyed-spore/ 2020-01-22T10:54:25+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/anders-vinther/attachment/nsf-ph-article-words-of-wisdom-from-anders-vinther/ 2020-01-22T16:23:17+00:00 https://www.pharmaceutical-business-review.com/news/roches-risdiplam-spinal-muscular/attachment/basel-1-2/ 2020-01-23T07:39:24+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-submits-nda-for-jzp-258-for-cataplexy-and-excessive-daytime-sleepiness-associated-with-narcolepsy/attachment/fdadrug-56/ 2020-01-23T10:15:27+00:00 https://www.pharmaceutical-business-review.com/news/lb-pharmaceuticals-initiates-patient-dosing-in-phase-1-study-of-lb-102-for-treatment-of-schizophrenia/attachment/test-214185_6406/ 2020-01-23T11:12:10+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/attachment/sgs-logo/ 2020-01-23T16:26:28+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/attachment/young-female-doctor-and-futuristic-medical-interface-concept/ 2020-01-23T16:33:37+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/attachment/respiratory-viral-infection/ 2020-01-23T16:33:48+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/attachment/clinical-molecule/ 2020-01-23T16:33:57+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/attachment/medicine-doctor-hand-touching-computer-interface-as-medical-network-connection-with-modern-virtual-screen-medical-technology-network-concept/ 2020-01-23T16:34:09+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/attachment/healthcare-technology/ 2020-01-23T16:39:26+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-tazverik-tepithelioid-sarcoma/attachment/fdadrug-57/ 2020-01-24T05:18:11+00:00 https://www.pharmaceutical-business-review.com/news/roches-tecentriq-miuc/attachment/basel-3/ 2020-01-27T07:35:14+00:00 https://www.pharmaceutical-business-review.com/news/highres-biosolutions-and-novo-nordisk-partner-to-transform-drug-discovery-in-automated-lab-of-future/attachment/drug-13/ 2020-01-27T10:09:46+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-pharmaceuticals-announces-real-world-data-on-telotristat-ethyls-antiproliferative-effects-in-patients-with-carcinoid-syndrome/attachment/test-214185_6407/ 2020-01-27T10:15:27+00:00 https://www.pharmaceutical-business-review.com/news/ds-8201-destiny-gastric01-trial/attachment/mitosis-3876669_640/ 2020-01-27T12:03:59+00:00 https://www.pharmaceutical-business-review.com/news/atnahs-pharma-astrazeneca-hypertension/attachment/astratablet-5/ 2020-01-28T07:30:52+00:00 https://www.pharmaceutical-business-review.com/news/accelerons-sotatercept-achieved-primary-and-secondary-endpoints-in-pulsar-trial-in-pulmonary-arterial-hypertension/attachment/laboratory-3827736_640/ 2020-01-28T10:50:21+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-allergan-irish/attachment/allergan/ 2020-01-28T11:45:08+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/data-fih-phase-1-trials/attachment/sgs-whitepaper-appropriate-and-reliable-data-required-for-conclusive-fih-trials/ 2020-01-28T14:14:02+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/modelling-simulation/attachment/sgs-whitepaper-consider-modeling-simulation/ 2020-01-28T14:15:30+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/ensuring-inspection-readiness-at-clinical-facilities/attachment/sgs-whitepaper-ensuring-inspection-readiness-at-clinical-facilities/ 2020-01-28T14:16:43+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/innovation-powers-research-development/attachment/sgs-whitepaper-innovation-powers-research-development/ 2020-01-28T14:18:50+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/managing-time-risk/attachment/sgs-whitepaper-managing-time-risk-in-early-phase-clinical-trials/ 2020-01-28T14:32:13+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/recruiting-studied-population/attachment/sgs-whitepaper-recruiting-the-studied-population-in-a-timely-manner/ 2020-01-28T14:33:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/regulator-proof-study/attachment/sgs-whitepaper-regulator-proof-your-study/ 2020-01-28T14:35:47+00:00 https://www.pharmaceutical-business-review.com/suppliers/sgs/whitepapers/respect-rules-protocol/attachment/sgs-whitepaper-respect-the-rules-of-the-clinical-trials-protocol/ 2020-01-28T14:38:01+00:00 https://www.pharmaceutical-business-review.com/news/alexion-achillion/attachment/achillion-2/ 2020-01-29T07:33:45+00:00 https://www.pharmaceutical-business-review.com/news/incyte-announces-that-true-ad2-trial-of-ruxolitinib-cream-met-its-primary-endpoint-in-patients-with-atopic-dermatitis/attachment/sunburn/ 2020-01-29T09:44:41+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-validates-kites-marketing-application-for-second-car-t-cell-therapy/attachment/dna-163466_6401/ 2020-01-29T10:57:57+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/manual-tablet-press/ 2020-01-29T11:39:16+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/capsule-polisher-2/ 2020-01-29T11:39:30+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/desktop-tablet-press/ 2020-01-29T11:39:34+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/empty-capsules-2/ 2020-01-29T11:39:39+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/excipients-2/ 2020-01-29T11:39:47+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/granulators/ 2020-01-29T11:39:53+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/manual-capsule-fillers-2/ 2020-01-29T11:39:58+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/mixers-2/ 2020-01-29T11:40:10+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/rotary-tablet-presses/ 2020-01-29T11:40:14+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/semi-automatic-and-fully-automatic-capsule-filling-machines-2/ 2020-01-29T11:40:18+00:00 https://www.pharmaceutical-business-review.com/products/empty-capsules/attachment/tablet-dedusters-2/ 2020-01-29T11:40:23+00:00 https://www.pharmaceutical-business-review.com/news/accenture-google-cloud-intient/attachment/800px-googleplex_hq_cropped/ 2020-01-29T11:58:05+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/regulatory-inspection-enforcement-trends/attachment/nsf-ph-article-fda-ema-regulatory-inspection-enforcement-trends/ 2020-01-29T15:22:32+00:00 https://www.pharmaceutical-business-review.com/news/lilly-selpercatinib-fda-priority-review/attachment/800px-2006_0219firstfujifolder0012-2/ 2020-01-30T06:10:35+00:00 https://www.pharmaceutical-business-review.com/news/vasopharm-completes-patient-enrollment-for-phase-3-traumatic-brain-injury-trial-nostra/attachment/science-1336663_6401/ 2020-01-30T11:12:00+00:00 https://www.pharmaceutical-business-review.com/news/aprea-therapeutics-apr-246-fda/attachment/fda_bldg_62_-_exterior_5161375340/ 2020-01-31T06:56:31+00:00 https://www.pharmaceutical-business-review.com/news/aprea-therapeutics-apr-246-fda/attachment/800px-fda_bldg_51_-_main_entrance_5161374834-3/ 2020-01-31T06:58:50+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mercks-dificid-to-treat-clostridioides-difficile-in-children-aged-six-months-and-older/attachment/fdadrug-58/ 2020-01-31T10:35:21+00:00 https://www.pharmaceutical-business-review.com/news/first-patient-with-advanced-breast-cancer-receives-first-dose-in-clinical-trial-of-glycomimetics-gmi-1359/attachment/test-214185_6408/ 2020-01-31T10:38:07+00:00 https://www.pharmaceutical-business-review.com/news/gsk-cepi-coronavirus/attachment/corona/ 2020-02-03T07:32:06+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-receives-positive-chmp-opinion-for-oncology-biosimilar-ruxience/attachment/pfizer-14/ 2020-02-03T09:42:03+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-withdraws-european-application-of-opdivo-plus-yervoy-for-first-line-treatment-of-advanced-nsclc/attachment/800px-bristol_myers_squibb_moreton_wirral_-_img_0369-2/ 2020-02-03T11:22:25+00:00 https://www.pharmaceutical-business-review.com/news/aimmune-palforzia-peanut-allergy-fda/attachment/aimmune_palforzia_capsule_image_fda_approval/ 2020-02-03T11:51:23+00:00 https://www.pharmaceutical-business-review.com/news/catalent-cdmo-masthercell/attachment/catalent/ 2020-02-04T07:25:18+00:00 https://www.pharmaceutical-business-review.com/news/teva-announces-positive-top-line-results-from-ajovy-clinical-trials-in-japan/attachment/teva/ 2020-02-04T09:15:45+00:00 https://www.pharmaceutical-business-review.com/news/bio-thera-solutions-announces-positive-top-line-results-for-bat1706-a-proposed-biosimilar-to-avastin/attachment/test-214185_6409/ 2020-02-04T10:00:01+00:00 https://www.pharmaceutical-business-review.com/news/recarbrio-habp-vabp-priority-review/attachment/fda_bldg_62_-_exterior_5161375340-2/ 2020-02-04T12:16:37+00:00 https://www.pharmaceutical-business-review.com/news/recarbrio-habp-vabp-priority-review/attachment/fda_bldg_51_-_main_entrance_5161374834-9/ 2020-02-04T12:17:43+00:00 https://www.pharmaceutical-business-review.com/contractors/actide/news/5th-european-conference-clinical-research/attachment/eucrof-2020-1110x633-1/ 2020-02-04T15:18:34+00:00 https://www.pharmaceutical-business-review.com/news/biomotiv-anteros-pharmaceuticals/attachment/anteros/ 2020-02-05T07:17:52+00:00 https://www.pharmaceutical-business-review.com/news/immix-doses-first-patient-in-us-in-its-phase-1b-2a-trial-in-patients-with-advanced-solid-tumours/attachment/cancer-5/ 2020-02-05T09:25:23+00:00 https://www.pharmaceutical-business-review.com/news/rebiotix-a-ferring-company-completes-enrollment-for-phase-3-clinical-trial-of-microbiota-based-rbx2660/attachment/test-214185_64010/ 2020-02-05T09:33:24+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-novel-coronavirus-antibodies/attachment/800px-new_eastview_office_bldg_jeh/ 2020-02-05T11:55:18+00:00 https://www.pharmaceutical-business-review.com/contractors/denny-bros/news/green-credentials-statistics/attachment/denny-logo/ 2020-02-05T14:14:11+00:00 https://www.pharmaceutical-business-review.com/contractors/denny-bros/news/green-credentials-statistics/attachment/denny2/ 2020-02-05T14:17:03+00:00 https://www.pharmaceutical-business-review.com/news/aimmune-xencor-food-allergy/attachment/vegetable/ 2020-02-06T07:35:50+00:00 https://www.pharmaceutical-business-review.com/news/genprex-to-focus-its-clinical-efforts-on-oncoprex-in-combination-therapy-with-osimertinib-for-nsclc/attachment/cancer-6/ 2020-02-06T09:39:24+00:00 https://www.pharmaceutical-business-review.com/news/alk-abello-and-x-chem-announce-drug-discovery-collaboration/attachment/science-1336663_6402/ 2020-02-06T10:35:43+00:00 https://www.pharmaceutical-business-review.com/news/apollo-covis-pharma/attachment/clovis-2/ 2020-02-07T07:58:37+00:00 https://www.pharmaceutical-business-review.com/news/realta-life-sciences-announces-fda-orphan-drug-designation-for-pic1-to-treat-hypoxic-ischemic-encephalopathy/attachment/fdadrug-59/ 2020-02-07T09:33:40+00:00 https://www.pharmaceutical-business-review.com/news/azafaros-completes-eur25m-series-a-financing-to-advance-rare-metabolic-disorders-pipeline/attachment/handshake-3298455_64028/ 2020-02-07T11:03:24+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/live-system-assessments/attachment/nsf-ph-white-paper-live-system-assessments-why-do-them/ 2020-02-07T16:11:19+00:00 https://www.pharmaceutical-business-review.com/news/roche-gantenerumab-alzheimers-disease/attachment/basel-4/ 2020-02-10T07:49:36+00:00 https://www.pharmaceutical-business-review.com/news/valeritas-announces-agreement-for-zealand-pharma-to-acquire-business-and-retain-employees/attachment/zealand-2/ 2020-02-10T10:03:20+00:00 https://www.pharmaceutical-business-review.com/news/elios-therapeutics-presents-new-phase-iib-data-for-personalized-cancer-vaccine-in-high-risk-melanoma-patients/attachment/syringe-4544448_6401/ 2020-02-10T10:48:50+00:00 https://www.pharmaceutical-business-review.com/news/eylea-panorama-trial-results/attachment/eyleaproductshot_1555343687374-hr/ 2020-02-10T11:40:09+00:00 https://www.pharmaceutical-business-review.com/news/nanobiotix-nbtxr3-head-neck/attachment/fdadrug-60/ 2020-02-11T07:51:21+00:00 https://www.pharmaceutical-business-review.com/news/biohavens-troriluzole-study-for-generalised-anxiety-disorder-misses-primary-endpoint/attachment/pharmatab/ 2020-02-11T10:07:45+00:00 https://www.pharmaceutical-business-review.com/news/moderna-announces-progress-in-prophylactic-vaccines-modality-with-cmv-vaccine-phase-2-study-data-now-expected-in-third-quarter-2020/attachment/syringe-4544448_6402/ 2020-02-11T10:13:23+00:00 https://www.pharmaceutical-business-review.com/news/lilly-solanezumab-dian-tu-study/attachment/800px-eli_lilly_corporate_center_indianapolis_indiana_usa/ 2020-02-11T11:34:56+00:00 https://www.pharmaceutical-business-review.com/casestudies/modelling-simulation-early-phase-clinical-trials/attachment/sgs-inspection-readiness/ 2020-02-11T14:31:28+00:00 https://www.pharmaceutical-business-review.com/casestudies/modelling-simulation-early-phase-clinical-trials/attachment/sgs-meaningful-data/ 2020-02-11T14:31:33+00:00 https://www.pharmaceutical-business-review.com/casestudies/modelling-simulation-early-phase-clinical-trials/attachment/sgs-consider-modeling-simulation-studies-in-early-phase-clinical-trials/ 2020-02-11T14:31:36+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-astellas-xtandi/attachment/pfizerworld-12/ 2020-02-12T07:51:45+00:00 https://www.pharmaceutical-business-review.com/news/ligand-agrees-to-acquire-core-assets-partnered-programmes-and-ion-channel-technologies-from-icagen/attachment/ligand-2/ 2020-02-12T09:57:20+00:00 https://www.pharmaceutical-business-review.com/news/capmatinib-fda-priority-review/attachment/novartis-tower-with-logo-image-5/ 2020-02-12T11:33:20+00:00 https://www.pharmaceutical-business-review.com/news/merck-keytruda-mtnbc-trial/attachment/keytruda-5/ 2020-02-13T07:44:14+00:00 https://www.pharmaceutical-business-review.com/news/alx-oncology-announces-closing-of-105m-series-c-financing/attachment/business-4107640_64010/ 2020-02-13T10:58:01+00:00 https://www.pharmaceutical-business-review.com/suppliers/resolver/whitepapers/improving-security-pharma/attachment/protecting-your-brand/ 2020-02-13T16:54:15+00:00 https://www.pharmaceutical-business-review.com/news/roche-chinese-tecentriq-chemotherapy/attachment/basel-5/ 2020-02-14T07:34:16+00:00 https://www.pharmaceutical-business-review.com/news/the-us-fda-accepts-for-priority-review-bristol-myers-squibbs-bla-for-liso-cel-for-adult-patients-with-relapsed-or-refractory-large-b-cell-lymphoma/attachment/bms-3/ 2020-02-14T09:46:54+00:00 https://www.pharmaceutical-business-review.com/news/deciphera-pharmaceuticals-announces-us-fda-acceptance-of-nda-and-priority-review-for-ripretinib-in-patients-with-advanced-gastrointestinal-stromal-tumours/attachment/fdadrug-61/ 2020-02-14T10:56:31+00:00 https://www.pharmaceutical-business-review.com/news/new-phase-3b-interim-data-from-stardust-study-show-majority-patients-with-moderately-to-severely-active-crohns-disease-achieved-clinical-remission-after-two-doses-of-stelara/attachment/jandj-4/ 2020-02-17T10:24:30+00:00 https://www.pharmaceutical-business-review.com/news/celltrion-showcases-positive-one-year-results-for-subcutaneous-formulation-of-infliximab-in-patients-with-active-crohns-disease-and-ulcerative-colitis/attachment/laboratory-3827745_6403/ 2020-02-17T11:31:41+00:00 https://www.pharmaceutical-business-review.com/news/opdivo-checkmate-025-study/attachment/bristol-myers-squibb_pharmaceutical_research_institute-by-sue-adair-3/ 2020-02-17T12:26:20+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/whitepapers/trademark-registration/attachment/eng-regmed-biz-services-trademark-registration/ 2020-02-17T16:05:59+00:00 https://www.pharmaceutical-business-review.com/news/novartis-beovu-wet-amd/attachment/novar-5/ 2020-02-18T06:40:06+00:00 https://www.pharmaceutical-business-review.com/news/ascletis-ind-filing-for-its-nash-drug-accepted-by-nmpa/attachment/liver-6/ 2020-02-18T09:59:23+00:00 https://www.pharmaceutical-business-review.com/news/lurbinectedin-fda-priority-review/attachment/cancer-cells-541954_6403/ 2020-02-18T12:10:56+00:00 https://www.pharmaceutical-business-review.com/news/audentes-therapeutics-gene/attachment/audentus/ 2020-02-19T07:02:55+00:00 https://www.pharmaceutical-business-review.com/news/alx-oncologys-alx148-receives-two-fast-track-designations-from-fda/attachment/fdadrug-63/ 2020-02-19T08:31:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/medical_devices/ 2020-02-19T09:55:24+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/representative/ 2020-02-19T09:55:31+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/marketing/ 2020-02-19T09:55:39+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/russian_gmp/ 2020-02-19T09:55:47+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/clinical_trials-2/ 2020-02-19T09:55:53+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/attachment/history/ 2020-02-19T09:56:01+00:00 https://www.pharmaceutical-business-review.com/suppliers/regmed/whitepapers/registration-pharmaceutical-products-substances/attachment/registration-of-pharmaceutical-products/ 2020-02-19T10:09:43+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-vyndaqel-ec-approval/attachment/pfizerworldheadquartersentrance-10/ 2020-02-19T11:53:39+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-astellas/attachment/fdadrug-64/ 2020-02-20T07:39:35+00:00 https://www.pharmaceutical-business-review.com/news/humanetics-acquires-manufacturing-assets-for-radioprotectant-drug/attachment/drug-14/ 2020-02-20T09:46:19+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-genentechs-tecentriq-as-first-line-treatment-of-certain-people-with-advanced-nsclc/attachment/genetech-0081967-3/ 2020-02-20T10:53:49+00:00 https://www.pharmaceutical-business-review.com/news/gsk-immatics-cancer-therapies/attachment/gsk-building/ 2020-02-21T05:39:21+00:00 https://www.pharmaceutical-business-review.com/news/forma-therapeutics-announces-ft-4202-granted-fast-track-designation-and-rare-paediatric-disease-designation-to-treat-sickle-cell-disease/attachment/fdadrug-65/ 2020-02-21T08:38:05+00:00 https://www.pharmaceutical-business-review.com/news/first-patient-dosed-with-transgenes-tg6002-in-colorectal-cancer-with-liver-metastases/attachment/science-1336663_6403/ 2020-02-21T10:11:50+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-migraine-vyepti/attachment/lundbeck-3/ 2020-02-24T07:48:37+00:00 https://www.pharmaceutical-business-review.com/news/genetron-health-innocare-collaborate-to-accelerate-development-and-commercialisation-of-novel-drugs-for-cancer-treatment/attachment/tablet-11/ 2020-02-24T09:39:10+00:00 https://www.pharmaceutical-business-review.com/news/harbour-biomed-announces-completion-of-phase-1-study-in-china-of-hbm9161-an-anti-fcrn-antibody/attachment/test-214185_64011/ 2020-02-24T10:46:31+00:00 https://www.pharmaceutical-business-review.com/news/lilly-trulicity-approval-fda/attachment/800px-eli_lilly_corporate_center_indianapolis_indiana_usa-2/ 2020-02-24T11:49:10+00:00 https://www.pharmaceutical-business-review.com/news/gsk-clover-coronavirus-vaccine/attachment/corona-2/ 2020-02-25T07:30:09+00:00 https://www.pharmaceutical-business-review.com/news/shionogis-fetroja-now-available-for-treatment-of-complicated-urinary-tract-infections-in-us/attachment/fetroja/ 2020-02-25T09:35:59+00:00 https://www.pharmaceutical-business-review.com/news/pandion-announces-first-subject-dosed-in-phase-1-trial-of-pt101-an-il-2-mutein-fc-fusion-therapy-for-autoimmune-disease/attachment/laboratory-3827745_6404/ 2020-02-25T11:01:02+00:00 https://www.pharmaceutical-business-review.com/news/alunbrig-fda-priority-review-nsclc/attachment/takeda-midosuji-bldg-01/ 2020-02-25T12:32:42+00:00 https://www.pharmaceutical-business-review.com/news/genentech-bicycle-therapeutics/attachment/archivnummer-4076-3/ 2020-02-26T06:42:52+00:00 https://www.pharmaceutical-business-review.com/news/lysogene-receives-fda-fast-track-designation-for-lys-saf302-gene-therapy-in-mps-iiia/attachment/fdadrug-66/ 2020-02-26T08:33:23+00:00 https://www.pharmaceutical-business-review.com/news/fda-astrazeneca-calquence/attachment/astra-1/ 2020-02-26T09:27:52+00:00 https://www.pharmaceutical-business-review.com/news/chmp-adopts-positive-opinion-for-astrazenecas-imfinzi-for-nsclc/attachment/astrazeneca-hq/ 2020-02-26T09:29:28+00:00 https://www.pharmaceutical-business-review.com/news/novartis-dndi-lxe408-visceral-leishmaniasis/attachment/novartis-tower-with-logo-image-6/ 2020-02-26T11:17:06+00:00 https://www.pharmaceutical-business-review.com/news/jtakeda-pvp-biologics/attachment/takedabuild/ 2020-02-27T07:13:36+00:00 https://www.pharmaceutical-business-review.com/news/gsk-innoviva-trelegy-ellipta-2/attachment/gsk-building-2/ 2020-02-28T08:10:37+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-enters-discovery-stage-collaboration-with-trutino-biosciences/attachment/medicine-tablet/ 2020-02-28T09:14:18+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-seeks-fda-accelerated-approval-for-tazverik-to-treat-follicular-lymphoma/attachment/fdadrug-62/ 2020-02-28T10:14:30+00:00 https://www.pharmaceutical-business-review.com/suppliers/n-side/whitepapers/clinical-trial-supply-optimization-benefits/attachment/optimize-your-clinical-trial-supply-chain-management-using-advanced-analytics/ 2020-02-28T10:33:08+00:00 https://www.pharmaceutical-business-review.com/suppliers/n-side/whitepapers/clinical-trial-supply-optimization-benefits/attachment/clinical-trial-supply-6/ 2020-02-28T10:33:12+00:00 https://www.pharmaceutical-business-review.com/suppliers/nsf-health-sciences-pharma-biotech-pbr/whitepapers/quality-systems-remediation/attachment/a-z-remediation/ 2020-02-28T17:02:53+00:00 https://www.pharmaceutical-business-review.com/news/emas-chmp-boehringers-nintedanib-to-treat-ssc-ild/attachment/boehringer/ 2020-03-02T07:48:15+00:00 https://www.pharmaceutical-business-review.com/news/medexus-expands-its-us-product-portfolio-by-acquiring-hematology-asset-ixinity/attachment/hema/ 2020-03-02T10:40:41+00:00 https://www.pharmaceutical-business-review.com/news/verastem-oncology-announces-new-strategic-direction-to-advance-its-clinical-development-programmes/attachment/laptop-3196481_64017/ 2020-03-02T11:27:55+00:00 https://www.pharmaceutical-business-review.com/news/harbour-biomed-hbm4003-fda/attachment/cancer-cells-541954_6404/ 2020-03-02T11:55:07+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-forty-seven/attachment/gilead-3/ 2020-03-03T07:17:28+00:00 https://www.pharmaceutical-business-review.com/news/takeda-completes-sale-of-select-otc-and-non-core-assets-to-acino/attachment/takeda-5/ 2020-03-03T09:23:22+00:00 https://www.pharmaceutical-business-review.com/news/advil-dual-action-with-acetaminophen-fda/attachment/glaxo_smith_kline_offices_on_the_great_west_road_at_brentford_-_panoramio-2/ 2020-03-03T11:38:21+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-givlaari-hepatic-porphyria/attachment/eurobuilding/ 2020-03-04T07:21:44+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/pome2-building-blocks-drug-design/attachment/wp_09-03/ 2020-03-04T10:08:45+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/pome2-building-blocks-drug-design/attachment/wp_23-03/ 2020-03-04T10:08:50+00:00 https://www.pharmaceutical-business-review.com/news/akouos-closes-105m-series-b-financing/attachment/shaking-hands-3091906_6407/ 2020-03-04T10:28:59+00:00 https://www.pharmaceutical-business-review.com/news/iktos-sri-covid-19-drug-discovery/attachment/artificial-intelligence-3382507_6406/ 2020-03-04T12:00:19+00:00 https://www.pharmaceutical-business-review.com/news/takeda-plasma-covid-19/attachment/corona-3/ 2020-03-05T07:40:55+00:00 https://www.pharmaceutical-business-review.com/news/scientists-from-merck-and-the-walter-and-eliza-hall-institute-of-medical-research-discover-novel-class-of-candidate-anti-malaria-agents/attachment/mosquito-3/ 2020-03-05T10:26:52+00:00 https://www.pharmaceutical-business-review.com/news/amunix-raises-73m-in-series-a-financing-led-by-omega-funds/attachment/handshake-3298455_640/ 2020-03-05T11:24:11+00:00 https://www.pharmaceutical-business-review.com/news/zydus-cirrhotic-nash-india/attachment/zydus-cadila-plant/ 2020-03-06T07:21:04+00:00 https://www.pharmaceutical-business-review.com/news/urovant-sciences-announces-us-fda-acceptance-of-nda-for-vibegron-to-treat-overactive-bladder/attachment/dental/ 2020-03-06T09:22:47+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-begins-proof-of-concept-trial-in-pnh-patients-with-oral-factor-d-inhibitor-bcx9930/attachment/test-214185_640-3/ 2020-03-06T09:31:28+00:00 https://www.pharmaceutical-business-review.com/news/novartis-isturisa-cushings-disease/attachment/novartis-tower-2/ 2020-03-09T07:35:46+00:00 https://www.pharmaceutical-business-review.com/news/mount-sinai-and-harbour-biomed-collaborate-to-advance-novel-biotherapies-to-treat-cancer-and-coronavirus-covid-19/attachment/coronavirus/ 2020-03-09T09:48:57+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-mavyret-hcv-study/attachment/abbvieus-2/ 2020-03-09T09:51:20+00:00 https://www.pharmaceutical-business-review.com/news/kalas-kpi-121-stride-3-trial/attachment/lab-3498584_640-2/ 2020-03-09T12:21:17+00:00 https://www.pharmaceutical-business-review.com/news/kuur-therapeutics-launches-to-develop-and-commercialise-off-the-shelf-car-nkt-cell-therapies/attachment/virus-12/ 2020-03-11T09:44:06+00:00 https://www.pharmaceutical-business-review.com/news/inmed-pharmaceuticals-announces-completed-enrollment-in-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/attachment/test-214185_640-4/ 2020-03-11T11:39:54+00:00 https://www.pharmaceutical-business-review.com/news/tourmaline-mm2-study-results/attachment/692px-takeda-midosuji-bldg-01/ 2020-03-11T12:48:52+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-opdivo/attachment/bmsfacility-5/ 2020-03-12T07:40:20+00:00 https://www.pharmaceutical-business-review.com/news/brii-biosciences-provides-funding-to-columbia-university-for-research-on-covid-19-and-other-coronaviruses/attachment/covid/ 2020-03-12T10:00:05+00:00 https://www.pharmaceutical-business-review.com/news/silverback-therapeutics-raises-78-5m-in-oversubscribed-series-b-financing/attachment/office-1209640_6401/ 2020-03-12T10:42:20+00:00 https://www.pharmaceutical-business-review.com/news/forty-seven-rocket-fanconi-anemia/attachment/business-4107640_640-2/ 2020-03-12T11:39:08+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/webinar-clinical-investigations/attachment/for-use-12-3-20-webinar-linkedin-posts-for-march-17-31-2020_linkedin/ 2020-03-12T14:21:06+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-jardiance-kidney/attachment/lilli-3/ 2020-03-13T07:41:25+00:00 https://www.pharmaceutical-business-review.com/news/artugen-therapeutics-announces-first-patient-dosed-with-art24/attachment/clostridium-2/ 2020-03-13T09:31:14+00:00 https://www.pharmaceutical-business-review.com/news/x4-pharmaceuticals-receives-breakthrough-therapy-designation-from-fda-for-mavorixafor-to-treat-whim-syndrome/attachment/fdadrug-50/ 2020-03-13T10:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-emd-serono-avelumab-la-scchn/attachment/pfizerworldheadquartersentrance-11/ 2020-03-16T06:42:15+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-to-explore-the-anti-coronavirus-effects-of-piclidenoson-in-collaboration-with-lewis-katz-school-of-medicine-at-temple-university/attachment/epidemic-4888794_640/ 2020-03-16T11:09:41+00:00 https://www.pharmaceutical-business-review.com/news/biostem-life-sciences-announces-expansion-contract-manufacturing-capabilities-and-research-and-development-laboratory/attachment/lab-3498584_6401/ 2020-03-16T11:13:41+00:00 https://www.pharmaceutical-business-review.com/news/lilly-incyte-baricitinib/attachment/lilli-4/ 2020-03-17T07:49:59+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-pharmaceuticals-to-acquire-tetraphase-pharmaceuticals/attachment/acquire-2/ 2020-03-17T09:40:23+00:00 https://www.pharmaceutical-business-review.com/news/ayala-pharmaceuticals-granted-us-fda-fast-track-designation-for-al101-to-treat-recurrent-or-metastatic-adenoid-cystic-carcinoma/attachment/fdadrug-67/ 2020-03-17T09:44:20+00:00 https://www.pharmaceutical-business-review.com/news/moderna-mrna-1273-coronavirus-trial/attachment/covid-19-4907621_640/ 2020-03-17T12:17:28+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-biontech-vaccine-covid-19/attachment/pfizer-15/ 2020-03-18T07:24:41+00:00 https://www.pharmaceutical-business-review.com/news/merck-announces-top-line-results-from-phase-3-trials-evaluating-gefapixant/attachment/tablet-12/ 2020-03-18T09:41:11+00:00 https://www.pharmaceutical-business-review.com/news/ribomic-enters-license-agreement-with-aju-pharma-for-rbm-007-in-age-related-macular-degeneration/attachment/handshake-3298455_640-1/ 2020-03-18T11:25:26+00:00 https://www.pharmaceutical-business-review.com/news/imfinzi-os-benefit-caspian-trial/attachment/cq5dam-web-1200-az1572_equipment-3/ 2020-03-18T12:10:57+00:00 https://www.pharmaceutical-business-review.com/news/entos-pharmaceuticals-fusogenix-covid-19/attachment/john/ 2020-03-19T07:41:27+00:00 https://www.pharmaceutical-business-review.com/news/entos-pharmaceuticals-fusogenix-covid-19/attachment/coronavirus-4914026_1280/ 2020-03-19T08:06:47+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-receives-orphan-drug-designation-from-fda-for-dcr-a1at-to-treat-alpha-1-antitrypsin-deficiency/attachment/fdadrug-68/ 2020-03-19T10:15:56+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-abrocitinib-jade-compare/attachment/pfizerworldheadquartersentrance-12/ 2020-03-19T12:29:53+00:00 https://www.pharmaceutical-business-review.com/news/roche-actemra-roactemra-pneumonia/attachment/basel-1-3/ 2020-03-20T07:32:45+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-treatment-for-paediatric-patients-with-any-strain-of-hepatitis-c/attachment/fdadrug-69/ 2020-03-20T09:17:06+00:00 https://www.pharmaceutical-business-review.com/news/novartis-multiple-sclerosis-mayzent/attachment/novartis-hq-6/ 2020-03-20T11:25:05+00:00 https://www.pharmaceutical-business-review.com/news/feinstein-institutes-covid-19/attachment/northwell/ 2020-03-23T08:27:59+00:00 https://www.pharmaceutical-business-review.com/news/amneal-accelerates-distribution-and-production-of-hydroxychloroquine-sulfate-to-meet-potential-needs-of-covid-19-patients-nationwide/attachment/corona-4/ 2020-03-23T11:17:44+00:00 https://www.pharmaceutical-business-review.com/news/design-therapeutics-launches-with-45m-to-develop-a-new-class-of-disease-modifying-therapies-for-serious-degenerative-disorders/attachment/test-214185_640-1/ 2020-03-23T11:27:07+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-cabenuva-approval/attachment/hiv-1903372_640/ 2020-03-23T12:19:28+00:00 https://www.pharmaceutical-business-review.com/products/clinical-research-phase/attachment/cta-6/ 2020-03-23T15:54:42+00:00 https://www.pharmaceutical-business-review.com/products/clinical-research-phase/attachment/cta-5/ 2020-03-23T15:54:54+00:00 https://www.pharmaceutical-business-review.com/products/clinical-research-phase/attachment/cta-4/ 2020-03-23T15:55:05+00:00 https://www.pharmaceutical-business-review.com/products/clinical-research-phase/attachment/cta-3/ 2020-03-23T15:55:17+00:00 https://www.pharmaceutical-business-review.com/products/clinical-research-phase/attachment/cta-2/ 2020-03-23T15:55:25+00:00 https://www.pharmaceutical-business-review.com/products/clinical-research-phase/attachment/cta-1/ 2020-03-23T15:55:35+00:00 https://www.pharmaceutical-business-review.com/products/short-time-patient-recruitment/attachment/recruitment/ 2020-03-23T15:58:44+00:00 https://www.pharmaceutical-business-review.com/products/monitoring-az-cro/attachment/monitoring-3/ 2020-03-23T16:01:40+00:00 https://www.pharmaceutical-business-review.com/products/pharmacovigilance-az-cro/attachment/pharmacovigiliance/ 2020-03-23T16:04:21+00:00 https://www.pharmaceutical-business-review.com/products/pharmacovigilance-az-cro/attachment/pharmacovigiliance-2/ 2020-03-23T16:04:57+00:00 https://www.pharmaceutical-business-review.com/products/biometry-statistics/attachment/biometry/ 2020-03-23T16:09:29+00:00 https://www.pharmaceutical-business-review.com/products/biometry-statistics/attachment/biometry-2/ 2020-03-23T16:10:57+00:00 https://www.pharmaceutical-business-review.com/products/regulatory/attachment/regulatory/ 2020-03-23T16:13:52+00:00 https://www.pharmaceutical-business-review.com/products/quality-az-cro/attachment/quality-2/ 2020-03-23T16:17:43+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/attachment/k_bleed_gross_vonoben/ 2020-03-23T16:40:13+00:00 https://www.pharmaceutical-business-review.com/news/genentech-polivy-brcombo-dlbcl-fda/attachment/genetech-0081967-4/ 2020-03-24T06:53:51+00:00 https://www.pharmaceutical-business-review.com/news/covacta-trial-actemra-covid-19/attachment/genetech-0081967-5/ 2020-03-24T06:55:09+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-gets-japanese-approval-for-skyrizi-to-treat-plaque-psoriasis-generalized-pustular-psoriasis-erythrodermic-psoriasis-and-psoriatic-arthritis/attachment/abbvie/ 2020-03-24T11:24:52+00:00 https://www.pharmaceutical-business-review.com/news/hoth-therapeutics-announces-agreement-to-joint-development-for-a-self-assembling-vaccine-sav-for-the-potential-prevention-of-coronavirus/attachment/epidemic-4952933_640/ 2020-03-24T11:31:02+00:00 https://www.pharmaceutical-business-review.com/news/avexis-zolgensma-sma-trials/attachment/dna-1903318_640-2/ 2020-03-24T15:47:58+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-pharmaceuticals-and-gen-sign-distribution-agreement-in-turkey-for-onpattro-patisiran/attachment/handshake-3298455_640-7/ 2020-03-26T11:40:11+00:00 https://www.pharmaceutical-business-review.com/news/infinity-ipi-549-urothelial-cancer/attachment/fda-drug-evaluation-research-center/ 2020-03-26T14:22:00+00:00 https://www.pharmaceutical-business-review.com/suppliers/netzsch/attachment/netzsch_logo_claim_proven_excellence_rgb_01_1500px/ 2020-03-26T16:02:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-vir-biotechnology-covid/attachment/corona-5/ 2020-03-27T08:22:41+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-squibbs-zeposia-oral-treatment-for-relapsing-forms-of-multiple-sclerosis/attachment/fda-drug/ 2020-03-27T09:18:59+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-designation-to-allovirs-viralym-m/attachment/laboratory-3827745_640-2/ 2020-03-27T11:35:59+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/attachment/k_bleed_gross_vonoben-2/ 2020-03-27T16:04:14+00:00 https://www.pharmaceutical-business-review.com/products/quality-az-cro/attachment/quality-2-2/ 2020-03-27T16:15:31+00:00 https://www.pharmaceutical-business-review.com/products/quality-az-cro/attachment/quality2-2/ 2020-03-27T16:21:40+00:00 https://www.pharmaceutical-business-review.com/news/clinones-remote-clinical-trial-patient-management-technology-allows-pharmaceutical-companies-to-continue-clinical-research-efforts-amidst-covid-19-pandemic-in-accordance-with-fda-guidelines/attachment/corona-6/ 2020-03-28T14:38:31+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-translate-bio-to-develop-novel-mrna-vaccine-for-covid-19-disease/attachment/corona-7/ 2020-03-30T07:05:32+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-roches-nda-for-xofluza-to-treat-influenza-in-children/attachment/basel-6/ 2020-03-30T09:22:25+00:00 https://www.pharmaceutical-business-review.com/suppliers/actide/attachment/actide_logo300x150/ 2020-03-30T11:21:59+00:00 https://www.pharmaceutical-business-review.com/news/aveo-oncology-and-biodesix-to-discontinue-cyfi-2-study-of-ficlatuzumab-in-aml-in-response-to-public-health-crisis/attachment/test-214185_640-2-2/ 2020-03-30T11:24:41+00:00 https://www.pharmaceutical-business-review.com/news/merck-vericiguat-victoria-trial/attachment/science-1336663_640-2/ 2020-03-30T12:45:42+00:00 https://www.pharmaceutical-business-review.com/products/clinical-research-phase/attachment/expertise2/ 2020-03-30T14:17:05+00:00 https://www.pharmaceutical-business-review.com/products/short-time-patient-recruitment/attachment/eastern-europe/ 2020-03-30T14:22:13+00:00 https://www.pharmaceutical-business-review.com/news/noveomes-st266-covid-19/attachment/corona-8/ 2020-03-31T08:43:11+00:00 https://www.pharmaceutical-business-review.com/news/imfinzi-durvalumab-approved-in-the-us-for-extensive-stage-small-cell-lung-cancer/attachment/fda-drug-evaluation-research-center-2/ 2020-03-31T10:38:59+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-submits-application-for-car-t-therapy-axicabtagene-ciloleucel-to-treat-patients-with-certain-relapsed-refractory-b-cell-lymphomas-in-japan/attachment/daichi-2/ 2020-03-31T10:39:58+00:00 https://www.pharmaceutical-business-review.com/news/aptorum-repurposed-drugs-coronavirus/attachment/covid-19-4927316_640-1/ 2020-03-31T12:28:43+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-sitryx-immunometabolic/attachment/eli-lilly-4/ 2020-04-01T07:19:05+00:00 https://www.pharmaceutical-business-review.com/news/vbi-vaccines-collaborates-with-the-national-research-council-of-canada-to-develop-pan-coronavirus-vaccine-candidate/attachment/epidemic/ 2020-04-01T09:44:20+00:00 https://www.pharmaceutical-business-review.com/products/we-advance-you/attachment/we-advance-you-2/ 2020-04-01T10:22:42+00:00 https://www.pharmaceutical-business-review.com/news/tsinghua-brii-bio-covid-19/attachment/coronavirus-4833754_640-2/ 2020-04-01T12:16:38+00:00 https://www.pharmaceutical-business-review.com/news/citius-novellus-covid-19/attachment/citrius/ 2020-04-02T08:20:49+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-announces-plans-for-ctp-543-phase-3-trials-in-alopecia-areata/attachment/hairloss/ 2020-04-02T09:16:59+00:00 https://www.pharmaceutical-business-review.com/news/beigene-doses-first-patient-in-phase-1b-2-trial-of-zw25-in-her2-positive-breast-cancer-and-gea/attachment/laboratory-3827745_640-1/ 2020-04-02T11:20:06+00:00 https://www.pharmaceutical-business-review.com/contractors/tosoh-bioscience/news/skillpak-pre-packed-columns/attachment/skillpak/ 2020-04-02T14:46:14+00:00 https://www.pharmaceutical-business-review.com/news/novartis-jakavi-covid-19/attachment/incyte/ 2020-04-03T07:02:38+00:00 https://www.pharmaceutical-business-review.com/news/amgen-and-adaptive-biotechnologies-announce-strategic-partnership-to-develop-therapeutic-to-prevent-or-treat-covid-19/attachment/amgen-2/ 2020-04-03T09:46:20+00:00 https://www.pharmaceutical-business-review.com/news/vir-and-alnylam-expand-collaboration-to-advance-investigational-rnai-therapeutics-targeting-host-factors-for-treatment-of-covid-19/attachment/corona-4916954_640/ 2020-04-03T11:36:22+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/02005-tif/ 2020-04-03T16:12:10+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/1_o2_sensor_inpro6800_12_frontview_original_5069-1/ 2020-04-03T16:12:14+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/1_o2_sensor_inpro6800_quickdisconnect2_original_5071-1/ 2020-04-03T16:12:20+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/2_inpro6850i_persp_ii_2_small-prints_42953-1/ 2020-04-03T16:12:26+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/4_inpro_7002_dn50_var_vp_persp2/ 2020-04-03T16:12:31+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/6_conductivity_inpro7108_25_vp_original_5005-1/ 2020-04-03T16:12:37+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/02005-tif-2/ 2020-04-03T16:12:43+00:00 https://www.pharmaceutical-business-review.com/products/7000rms/attachment/10_7000rms_new_fluidics_front_small-prints_61017-1/ 2020-04-03T16:16:52+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-acceleron/attachment/bms-4/ 2020-04-06T08:16:20+00:00 https://www.pharmaceutical-business-review.com/news/iveric-bio-announces-fast-track-designation-from-us-fda-for-zimura-to-treat-geographic-atrophy-secondary-to-dry-age-related-macular-degeneration/attachment/fda-drug-2/ 2020-04-06T09:20:21+00:00 https://www.pharmaceutical-business-review.com/news/shenogen-enters-into-an-exclusive-license-with-bioardis-to-develop-and-commercialise-fgfr4-kinase-inhibitor-for-asian-market/attachment/handshake-3298455_640-11/ 2020-04-06T11:40:28+00:00 https://www.pharmaceutical-business-review.com/news/gsk-nucala-synapse-trial-results/attachment/1200px-glaxo_smith_kline_offices_on_the_great_west_road_at_brentford_-_panoramio/ 2020-04-06T12:22:07+00:00 https://www.pharmaceutical-business-review.com/contractors/wek-tec/news/multi-task-uv-light-system/attachment/wt-multi-use-puv-system-m1r1/ 2020-04-06T12:47:22+00:00 https://www.pharmaceutical-business-review.com/products/6000toci/attachment/11_6000toci_pds_left_cutout_small-prints_55710-1/ 2020-04-06T13:10:22+00:00 https://www.pharmaceutical-business-review.com/products/m800/attachment/12_m800-2/ 2020-04-06T13:20:59+00:00 https://www.pharmaceutical-business-review.com/products/inpro6860i-220ma/attachment/13_inpro_6860i/ 2020-04-06T13:27:42+00:00 https://www.pharmaceutical-business-review.com/products/ph-sensor-inpro3253i-120/attachment/21_ph_inpro3253/ 2020-04-06T13:41:16+00:00 https://www.pharmaceutical-business-review.com/products/sensor-pureo3/attachment/23_pureo3/ 2020-04-06T13:46:20+00:00 https://www.pharmaceutical-business-review.com/products/unicond-2/attachment/24_unicond-sanitary_label_front_original_17191-1/ 2020-04-06T13:49:34+00:00 https://www.pharmaceutical-business-review.com/news/gsk-vir-biotechnology-coronaviruses/attachment/coronavirus-2/ 2020-04-07T07:55:16+00:00 https://www.pharmaceutical-business-review.com/news/gsk-vir-biotechnology-coronaviruses/attachment/corona-virus/ 2020-04-07T07:56:29+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-second-genome-announce-strategic-collaboration-in-biomarker-and-inflammatory-bowel-disease-drug-discovery/attachment/gilead-4/ 2020-04-07T08:39:35+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-and-dicerna-form-rnai-therapeutics-collaboration-on-alpha-1-liver-disease/attachment/handshake-3655926_640-3/ 2020-04-07T10:57:32+00:00 https://www.pharmaceutical-business-review.com/news/takeda-alunbrig-alk-nsclc/attachment/692px-takeda-midosuji-bldg-01-1/ 2020-04-07T11:31:22+00:00 https://www.pharmaceutical-business-review.com/news/montreal-heart-institute-covid-19/attachment/covid19/ 2020-04-08T08:14:52+00:00 https://www.pharmaceutical-business-review.com/news/beam-therapeutics-licenses-sirion-biotechs-lentiboost-technology-for-its-car-t-pipeline/attachment/handshake-3298455_640-12/ 2020-04-08T10:45:06+00:00 https://www.pharmaceutical-business-review.com/news/cromsource-announces-launch-of-covid-19-clinical-trial/attachment/chromsource/ 2020-04-08T11:10:34+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-lumasiran-ph1-approval/attachment/fda-drug-evaluation-research-center-3/ 2020-04-08T11:23:08+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-braftovi-cetuximab/attachment/pfizer-16/ 2020-04-09T07:54:39+00:00 https://www.pharmaceutical-business-review.com/news/oncoimmune-receives-fda-approval-for-covid-19-clinical-trial/attachment/immune/ 2020-04-09T08:52:03+00:00 https://www.pharmaceutical-business-review.com/news/acceleron-receives-fda-breakthrough-therapy-designation-for-sotatercept-in-pulmonary-arterial-hypertension/attachment/fda-drug-evaluation-research-center-4/ 2020-04-09T11:20:22+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-koselugo/attachment/medimmune-gaithersburg-us-2/ 2020-04-13T08:44:03+00:00 https://www.pharmaceutical-business-review.com/news/enzychem-lifesciences-announces-filing-of-us-provisional-patent-for-ec-18-to-treat-covid-19/attachment/coronacompound/ 2020-04-13T09:57:17+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-pharmaceuticals-files-for-regulatory-clearance-to-begin-phase-1-2a-study-of-aro-enac-for-treatment-of-cystic-fibrosis/attachment/test-214185_640-3-2/ 2020-04-13T11:32:59+00:00 https://www.pharmaceutical-business-review.com/news/lilly-baricitinib-covid-19/attachment/lilly-corporate-center/ 2020-04-13T12:46:41+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-blackstone-rnai-medicines/attachment/alnylam/ 2020-04-14T08:45:04+00:00 https://www.pharmaceutical-business-review.com/news/ascletis-receives-ind-approval-for-its-hiv-drug-asc09f/attachment/pill-5/ 2020-04-14T09:44:50+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/cyclic-sulfonamides-drug-design/attachment/wp_20-04/ 2020-04-14T10:43:47+00:00 https://www.pharmaceutical-business-review.com/suppliers/enamine/whitepapers/cyclic-sulfonamides-drug-design/attachment/wp_27-04/ 2020-04-14T10:43:52+00:00 https://www.pharmaceutical-business-review.com/news/ridgeback-biotherapeutics-announces-mhra-clearance-to-begin-human-testing-of-eidd-2801-in-uk-for-covid-19/attachment/covid-19-4961257_640-1/ 2020-04-14T11:21:03+00:00 https://www.pharmaceutical-business-review.com/news/hope-biosciences-covid-19-stem-cell/attachment/coronavirus-4833754_640-3/ 2020-04-14T12:40:54+00:00 https://www.pharmaceutical-business-review.com/products/we-advance-you/attachment/key-strengths/ 2020-04-14T13:12:23+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/elearning-virtual-training/attachment/17639957-female-office-worker-typing-on-the-keyboard/ 2020-04-14T16:04:23+00:00 https://www.pharmaceutical-business-review.com/news/gsk-sanofi-covid-19/attachment/gsk-7/ 2020-04-15T08:09:28+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-receives-fast-track-designation-for-vutrisiran-to-treat-polyneuropathy-of-hattr-amyloidosis/attachment/fda-drug-3/ 2020-04-15T09:37:17+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-biotech-covid-19-vaccine-trial/attachment/syringe-417786_640/ 2020-04-15T12:15:30+00:00 https://www.pharmaceutical-business-review.com/news/novartis-tscan-solid-tumours/attachment/novartis-tower-3/ 2020-04-16T08:12:18+00:00 https://www.pharmaceutical-business-review.com/news/forma-therapeutics-receives-fda-orphan-drug-designation-for-ft-4202-to-treat-sickle-cell-disease/attachment/fda-drug-4/ 2020-04-16T09:50:40+00:00 https://www.pharmaceutical-business-review.com/news/merck-announces-us-launch-of-ontruzant-a-biosimilar-of-herceptin/attachment/merck-tablet/ 2020-04-16T09:59:27+00:00 https://www.pharmaceutical-business-review.com/news/barda-commits-483m-to-moderna-for-covid-19-vaccine/attachment/bardavirus/ 2020-04-17T08:14:03+00:00 https://www.pharmaceutical-business-review.com/news/starpharmas-spl7013-shows-significant-activity-against-sars-cov-2/attachment/melborne/ 2020-04-17T09:51:38+00:00 https://www.pharmaceutical-business-review.com/news/legochem-biosciences-iksuda-collaborate-to-develop-antibody-drug-conjugates/attachment/drugconjugate/ 2020-04-17T09:59:18+00:00 https://www.pharmaceutical-business-review.com/products/unicond-2/attachment/ds_ism_sensors_en_58087009_aug15/ 2020-04-17T14:49:39+00:00 https://www.pharmaceutical-business-review.com/products/sensor-pureo3/attachment/ds_ozone_pureo3_sensor_pa2042en_nov19_revc/ 2020-04-17T14:52:47+00:00 https://www.pharmaceutical-business-review.com/products/ph-sensor-inpro3253i-120/attachment/ff_ph_lowmaint_cpielectrodese52121120may05/ 2020-04-17T15:08:36+00:00 https://www.pharmaceutical-business-review.com/products/inpro6860i-220ma/attachment/pa2033en_a_ds_o2_inpro6860i_hd_lr/ 2020-04-17T15:08:54+00:00 https://www.pharmaceutical-business-review.com/products/m800/attachment/default_table_m800_en_01_11/ 2020-04-17T15:13:28+00:00 https://www.pharmaceutical-business-review.com/products/6000toci/attachment/pb_toc_6000toci_sensor_en_58087131_dec18/ 2020-04-17T15:14:09+00:00 https://www.pharmaceutical-business-review.com/products/7000rms/attachment/pa2036en_ds_7000rms_services_oct19_reva/ 2020-04-17T15:14:18+00:00 https://www.pharmaceutical-business-review.com/products/inpro-8100/attachment/td_inpro8000_series_turbiditysensor_en_52800246_may15/ 2020-04-17T15:14:29+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7108-25-vp/attachment/ds_conductivitysensor_inpro7100_en_52900359_jul17/ 2020-04-17T15:14:42+00:00 https://www.pharmaceutical-business-review.com/products/inpro-5000i/attachment/5000i-brochure/ 2020-04-17T15:16:19+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7100/attachment/td_conductivity_sensor_inpro7000-vp_en_52002183_jul15/ 2020-04-17T15:16:27+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7002-tc-vp-sensor/attachment/ss_pharma_modelling_co2_faster_scaleup_fermentation_en_july06/ 2020-04-17T15:16:46+00:00 https://www.pharmaceutical-business-review.com/products/inpro-6800/attachment/ff_do_en_52200957_june2012/ 2020-04-17T15:16:58+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/5000i-brochure/attachment/5000i-brochure-2/ 2020-04-17T15:25:20+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/m800-multi-parameter-transmitter/attachment/default_table_m800_en_01_11-2/ 2020-04-17T15:28:53+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/inpro-7100-series/attachment/ds_conductivitysensor_inpro7100_en_52900359_jul17-2/ 2020-04-17T15:33:08+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/pureo3-dissolved-ozone-sensor/attachment/ds_ozone_pureo3_sensor_pa2042en_nov19_revc-2/ 2020-04-17T15:38:31+00:00 https://www.pharmaceutical-business-review.com/contractors/nsf-health-sciences-pharma-biotech-pbr/news/remote-virtual-gmp-audits/attachment/teamwork-works-with-a-laptop-concept-of-internet-sharing-and-interconnection-double-exposure/ 2020-04-17T15:40:16+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/ph-electrodes-systems/attachment/ff_do_en_52200957_june2012-2/ 2020-04-17T15:43:07+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/oxygen-sensor-inpro-6860ihd/attachment/ff_do_en_52200957_june2012-3/ 2020-04-17T15:46:08+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/7000rms-services/attachment/ff_do_en_52200957_june2012-4/ 2020-04-17T15:48:22+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/7000rms-services/attachment/pa2036en_ds_7000rms_services_oct19_reva-2/ 2020-04-17T15:49:21+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/oxygen-sensor-inpro-6860ihd/attachment/pa2033en_a_ds_o2_inpro6860i_hd_lr-2/ 2020-04-17T15:53:17+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/ph-electrodes-systems/attachment/ff_ph_lowmaint_cpielectrodese52121120may05-2/ 2020-04-17T15:57:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/pharmacontrol-electronic-pharma-business-review/whitepapers/ism-sensors-m800-m300-transmitters/attachment/default_table_m800_en_01_11-3/ 2020-04-17T15:58:02+00:00 https://www.pharmaceutical-business-review.com/suppliers/pharmacontrol-electronic-pharma-business-review/whitepapers/ism-sensors-m800-m300-transmitters/attachment/ds_ism_sensors_en_58087009_aug15-2/ 2020-04-17T15:59:37+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/dissolved-oxygen-measuring-systems/attachment/ff_do_en_52200957_june2012-5/ 2020-04-17T16:01:32+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/6000toci-sensor/attachment/pb_toc_6000toci_sensor_en_58087131_dec18-2/ 2020-04-17T16:04:05+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/whitepapers/inpro-8000-series-turbidity-sensor/attachment/td_inpro8000_series_turbiditysensor_en_52800246_may15-2/ 2020-04-17T16:06:21+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-tukysa/attachment/tukysa/ 2020-04-20T08:20:46+00:00 https://www.pharmaceutical-business-review.com/news/revive-therapeutics-partners-with-complete-phytochemical-solutions-to-advance-research-initiatives-for-psilocybin-based-pharmaceutical-products/attachment/handshake-3298455_640-19/ 2020-04-20T11:23:23+00:00 https://www.pharmaceutical-business-review.com/news/ascendis-transcon-pth-hypoparathyroidism/attachment/test-214185_640-4-2/ 2020-04-20T11:55:27+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/attachment/novasep-logo/ 2020-04-20T14:51:53+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/attachment/_b__0031/ 2020-04-20T15:12:04+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/attachment/_b__1211/ 2020-04-20T15:12:11+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/attachment/biosc-pilot-5-modules/ 2020-04-20T15:12:19+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/attachment/biosc_lab_blurred/ 2020-04-20T15:12:38+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/attachment/hipersep-l-lc590-detoure/ 2020-04-20T15:12:52+00:00 https://www.pharmaceutical-business-review.com/suppliers/novasep/attachment/p1440075-2/ 2020-04-20T15:13:01+00:00 https://www.pharmaceutical-business-review.com/news/novartis-hydroxychloroquine-covid-19/attachment/novar-6/ 2020-04-21T08:32:55+00:00 https://www.pharmaceutical-business-review.com/news/alexion-announces-plans-to-initiate-phase-3-study-of-ultomiris-ravulizumab-cwvz-in-hospitalised-patients-with-severe-covid-19/attachment/alex/ 2020-04-21T09:22:39+00:00 https://www.pharmaceutical-business-review.com/news/opdivo-yervoy-checkmate-743/attachment/bristol_myers_squibb_moreton_wirral_-_img_0369/ 2020-04-21T11:12:34+00:00 https://www.pharmaceutical-business-review.com/news/wavelength-pharmaceuticals-expands-supplies-of-key-drug-ingredients-for-critically-ill-covid-19-patients/attachment/covid-19-4922384_640-7/ 2020-04-21T11:20:14+00:00 https://www.pharmaceutical-business-review.com/contractors/vetter_pharma_international/news/2020-cmo-leadership-awards/attachment/cmola_master_stacked/ 2020-04-21T13:54:16+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gets-ec-approval-for-nintedanib-to-treat-ssc-ild/attachment/boehngar/ 2020-04-22T08:41:49+00:00 https://www.pharmaceutical-business-review.com/news/nexus-pharmaceuticals-announces-approval-of-emerphed-injection/attachment/emerphed-v1/ 2020-04-22T09:21:16+00:00 https://www.pharmaceutical-business-review.com/news/hope-biosciences-announces-third-fda-approved-clinical-trial-for-covid-19/attachment/test-214185_640-4-3/ 2020-04-22T11:04:28+00:00 https://www.pharmaceutical-business-review.com/news/gilead-onko-innate-nk-cells/attachment/cancer-cells-541954_6402-2/ 2020-04-22T11:31:58+00:00 https://www.pharmaceutical-business-review.com/news/novartis-kymriah-follicular-lymphoma/attachment/novartis-tower-4/ 2020-04-23T08:28:56+00:00 https://www.pharmaceutical-business-review.com/news/emergex-signs-agreement-with-george-mason-university-for-highly-pathogenic-rna-virus-studies/attachment/university/ 2020-04-23T09:11:18+00:00 https://www.pharmaceutical-business-review.com/news/akili-announces-endeavor-digital-attention-treatment-is-available-for-children-with-adhd-under-fdas-covid-19-enforcement-discretion-guidance/attachment/endeavor_1/ 2020-04-23T11:12:04+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-covid-19-farxiga/attachment/astraglobe/ 2020-04-24T08:36:37+00:00 https://www.pharmaceutical-business-review.com/news/agastiya-biotech-proceeding-with-drug-candidate-for-covid-19/attachment/corvirus/ 2020-04-24T09:16:48+00:00 https://www.pharmaceutical-business-review.com/news/affinivax-announces-120m-series-b-financing-to-advance-pipeline-of-novel-maps-vaccines-and-immunotherapies/attachment/syringe-1884758_640-2/ 2020-04-24T11:19:58+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-menquadfi-menquadfi-vaccine/attachment/meningo/ 2020-04-27T09:09:56+00:00 https://www.pharmaceutical-business-review.com/news/janssen-announces-submission-of-two-applications-to-us-fda-seeking-approval-of-simponi-aria-to-treat-polyarticular-juvenile-idiopathic-arthritis-and-juvenile-psoriatic-arthritis/attachment/jandj-5/ 2020-04-27T10:22:54+00:00 https://www.pharmaceutical-business-review.com/news/lynparza-pancreatic-cancer-fda-orphan/attachment/lynparza/ 2020-04-27T11:27:00+00:00 https://www.pharmaceutical-business-review.com/news/verastem-oncology-announces-preliminary-data-from-investigator-initiated-study-highlighting-clinical-activity-of-raf-mek-and-fak-combination-in-kras-mutant-tumors/attachment/science-1336663_640-1/ 2020-04-27T11:35:51+00:00 https://www.pharmaceutical-business-review.com/suppliers/schott-pharma/attachment/portrait-of-female-doctor-with-stethoscope/ 2020-04-27T12:42:33+00:00 https://www.pharmaceutical-business-review.com/suppliers/schott-pharma/attachment/schott-map2/ 2020-04-27T12:54:34+00:00 https://www.pharmaceutical-business-review.com/products/schott-iq/attachment/glass-primary-packaging-logo/ 2020-04-27T14:14:56+00:00 https://www.pharmaceutical-business-review.com/products/schott-iq/attachment/schott_pp_internet_bilder_720x390px5/ 2020-04-27T14:16:38+00:00 https://www.pharmaceutical-business-review.com/products/schott-toppac/attachment/toppac-header/ 2020-04-27T14:20:29+00:00 https://www.pharmaceutical-business-review.com/products/pharma-consulting/attachment/sps_key_visual2/ 2020-04-27T14:24:30+00:00 https://www.pharmaceutical-business-review.com/products/glass-ampoules/attachment/schott_pp_internet_bilder_1920x542px1/ 2020-04-27T14:57:12+00:00 https://www.pharmaceutical-business-review.com/products/schott-syringes/attachment/schott_pp_internet_bilder_1920x542px4/ 2020-04-27T15:01:27+00:00 https://www.pharmaceutical-business-review.com/news/takeda-mobocertinib-nsclc/attachment/takeda-6/ 2020-04-28T08:27:05+00:00 https://www.pharmaceutical-business-review.com/news/moderna-announces-ind-submitted-to-us-fda-for-phase-2-study-of-mrna-1273-against-novel-coronavirus/attachment/moderna/ 2020-04-28T10:31:48+00:00 https://www.pharmaceutical-business-review.com/news/affinia-vertex-aav-capsids-deal/attachment/dna-1811955_640/ 2020-04-28T11:17:26+00:00 https://www.pharmaceutical-business-review.com/suppliers/mettler-toledo/attachment/mettler-value/ 2020-04-28T11:17:43+00:00 https://www.pharmaceutical-business-review.com/news/merck-and-institute-for-systems-biology-collaborate-to-define-molecular-mechanisms-of-sars-cov-2-infection-and-identify-potential-prognostic-biomarkers/attachment/virus-4835301_640-2/ 2020-04-28T11:23:09+00:00 https://www.pharmaceutical-business-review.com/products/inpro-8200-turbidity-sensor/attachment/8_inpro8200-2/ 2020-04-28T12:06:00+00:00 https://www.pharmaceutical-business-review.com/products/ph-sensor-inpro3253i-120/attachment/20_ph_inpro3253/ 2020-04-28T12:26:15+00:00 https://www.pharmaceutical-business-review.com/products/inpro-8200-chemical-pharma/attachment/8_inpro8200/ 2020-04-28T13:32:03+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7100/attachment/5_inpro7100/ 2020-04-28T14:41:03+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7100/attachment/3_inpro_5000i/ 2020-04-28T14:41:11+00:00 https://www.pharmaceutical-business-review.com/products/inpro-7100/attachment/5_inpro7100_vp_front_pds_original_6163-11/ 2020-04-28T14:43:25+00:00 https://www.pharmaceutical-business-review.com/products/inpro-5000i/attachment/3_inpro_5000i_front_original_18066-11/ 2020-04-28T14:45:10+00:00 https://www.pharmaceutical-business-review.com/products/inpro-5000i/attachment/5_inpro7100_vp_front_pds_original_6163-11-2/ 2020-04-28T14:45:35+00:00 https://www.pharmaceutical-business-review.com/news/novartis-canakinumab-pneumonia/attachment/novar-7/ 2020-04-29T08:18:13+00:00 https://www.pharmaceutical-business-review.com/news/quotient-sciences-and-cytoagents-accelerate-potential-treatment-for-covid-19-cytokine-storm/attachment/cytokinen/ 2020-04-29T09:15:08+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-keynote-181/attachment/keytruda-100mg-4ml-vial-and-carton/ 2020-04-29T10:52:45+00:00